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Abstract 
Abstract 
Cardiovascular diseases (CVD) remain the most common cause of death in the United 
States. Additionally, peripheral artery disease affects thousands of people each year. A major 
underlying cause of these diseases is the occlusion of the coronary or peripheral arteries due to 
arteriosclerosis. To overcome this, a number of vascular interventions have been developed 
including angioplasty, stenting, endarterectomies and bypass grafts. Although all of these 
methods are capable of restoring blood flow to the distal organ after occlusion, they are all 
plagued by unacceptably high restenosis rates. While the biological reactions that occur as a 
result of each of these methods differ, the initiating factor of both the primary atherosclerosis 
and subsequent failure of vascular interventions appears to be intimal hyperplasia (IH). 
Intimal hyperplasia is most simply defined as the expansion of multiple layers of cells 
internally to the internal elastic lamina of the blood vessel. This excessive cellular growth leads 
to arterial stenosis, plaque formation and inflammatory reactions. Despite extensive research 
the underlying factors that cause IH remain unclear. A quantity of research to date has 
implicated endothelial cell mechanosensation as the mechanism by which IH is initiated with 
evidence positively correlating wall shear stress with IH. Others, however, have demonstrated 
that changes in the stresses applied to the wall in vitro can modulate IH independent of 
hemodynamic shear stress. Thus, relations between wall tensile stress and IH in vivo may shed 
light on the underlying mechanisms of IH. Since noninvasive measurement of wall tensile stress 
in vivo is difficult, it is most feasible to measure oscillatory wall strain which is intimately 
related to wall tensile stress through the mechanical properties of the arterial wall. In this 
dissertation, we hypothesize that reductions in oscillatory wall strain precede the formation of 
intimal hyperplasia in a murine model.   
To test our hypothesis, we first developed a novel, high spatial and temporal resolution 
method to measure oscillatory wall strains in the murine common carotid artery. We validated 
this method both in vitro using an arterial phantom and in vivo using a murine model of 
abdominal aortic aneurysms. To assess relationships between strain and IH, we applied our 
strain measurement technique to a recently developed mouse model of IH. In this model, a 
suture is used to create a focal stenosis and reduce flow through the common carotid artery by 
85%; resulting in proximal IH formation. Using this approach, we identified a relationship 
between oscillatory strain reductions and IH. Subsequent analysis demonstrated that early 
reductions in mechanical strain just 4 days after focal stenosis creation correlate with IH 
formation nearly 1 month later.  
Since IH is not expected to form by day 4 in this model, we went on to assess changes in 
gross vascular morphology at day 4. We discovered that, although strains are significantly 
reduced by day 4, no significant IH can be observed, suggesting that changes in wall structure 
are resulting in strain reductions. At day 4 post-op, we observed cellular proliferation and 
leukocyte recruitment to the wall without intimal hyperplasia. These studies suggest that early 
reductions in mechanical strain may be an important predictor of IH formation.  Clinically, this 
relation could be important for the development of novel techniques for predicting IH 
formation before it becomes hemodynamically significant.
1 
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1 Overview 
1.1 Introduction 
The 2013 update of the American Heart Association’s heart disease and stroke statistics 
indicates that 32.3% of deaths in the United States list cardiovascular disease (CVD) as the 
underlying cause and that more than 50% of death certificates mention CVD as a contributing 
factor to death.1  Although the death rates per 100,000 Americans due to CVD have declined 
from 864.9 in 1999 to 243.9 in 2009, the prevalence of CVD is expected to rise from 35.6% to 
40.8% by the year 2030.1 These statistics indicate a real clinical need to improve our 
understanding and treatment of CVD and its causes. 
Coronary artery disease (CAD) and peripheral artery disease (PAD) both contribute 
significantly to mortality and morbidity in the United States, each affecting more than 14 
million Americans.1  CAD is estimated to have been responsible for over 1.2 million hospital 
stays in 2004 and was determined the most expensive condition treated in hospitals and caused 
more than 50% of cardiovascular events.1 Similarly, PAD caused 14,000 deaths in 2009 and also 
contributes to CVD prevalence.2 
Although a number of evidence based interventions have been applied to treat CAD and 
PAD, these interventions fail to address the underlying causes of the diseases.3 Present day 
treatments for CAD and PAD include angioplasty, stents, endarterectomies, and bypass grafts. 
Although these treatments have decreased the mortality rates due to arterial occlusive diseases, 
all continue to suffer from unacceptably high failure rates which in some cases exceed 50%.2, 4, 5 
While the biologic adaptation underlying the failure of each of these treatments differs subtly, 
the underlying cause of both the primary arterial occlusive disease and the subsequent 
treatments appears to be intimal hyperplasia (IH).6-11  
2 
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Intimal hyperplasia is characterized by the expansion of multiple layers of cells expressing 
alpha smooth muscle actin (αSMA) internally to the internal elastic lamina of a blood vessel 
(Figure 1-1).3, 12 This expansion often results in the appearance and aggregation of foam cells, 
accumulation of cholesterol and the eventual formation of atherosclerotic plaques. 3, 12, 13 In the 
healthy adult artery, smooth muscle cells (SMCs) remain outside the internal elastic lamina and 
maintain a homeostatic level of growth to maintain vessel size and structure with a very low 
rate of both proliferation and death.14-18 In the pathological state, however, SMCs can be seen to 
migrate into the intimal compartment of the vessel. This proliferative and migratory response is 
the primary underlying mechanism that initiates arteriosclerosis, arterial occlusion and the 
eventual end organ ischemia associated with CAD, PAD and virtually all contemporary 
treatments of the disease.3, 6-11, 14  
 
Figure 1-1: Staining of vessels with intimal hyperplastic lesions. A) Masson’s Trichrome stain of a mouse 
carotid artery with intimal hyperplasia. B) Masson’s Trichrome stain with overlaid green tracings of the internal and 
external elastic laminae. C) Close-up of region shown in B. D) Dual stain of Ki-67 (red) and alpha smooth muscle 
actin (green) showing cells expressing alpha smooth actin within the internal elastic lamina and cellular proliferation 
at the edge of the vessel lumen. 
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Although a number of hypotheses have been made as to why IH occurs, a long line of 
evidence suggests that cellular sensing of the mechanical environment that the artery is exposed 
to provides the cues that initiate IH. Low wall shear stress,19 high wall tensile stress 20 and the 
combination of both factors 21 may play a role in the formation of IH in the vessel wall. Others 
suggest that wall strain, which is closely related to wall stress, may play a more direct role in IH 
formation.22 Although a number of researchers have implicated wall shear stress as the primary 
factor affecting IH formation,23-26 shear-based explanations alone fail to predict many aspects of 
IH. 27, 28 A leading hypothesis is that the arterial wall actively maintains a homeostatic level of 
wall stress.29-31 This theory is supported by the observation that the number of lamellar units in 
any given artery  is proportional to blood vessel diameter.32  By maintaining this relationship, 
the vascular wall keeps the mechanical tension per lamellar unit within an amazingly narrow 
physiological range, even across numerous mammalian species.32 Since wall stress and strain 
are intimately related through the mechanical properties of the vessel wall, others have 
suggested that wall strain, not stress, is the underlying state sensed by the cell.33 The sheer 
volume of literature relating the mechanical environment to IH suggests that in vivo assessment 
of arterial mechanics may be useful for the characterization, diagnosis and prevention of IH and 
arterial occlusive diseases.  
Given that wall stress is difficult to measure accurately in vivo, analysis of wall strain 
represents a more promising mechanical property to assess in living models. In vivo wall strain 
has been assessed using a number of methodologies which are both invasive and non-invasive 
including MRI,34, 35 ultrasound36 and high speed light imaging based methods37. Herein we 
4 
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develop a novel method to assess cyclic arterial strain in a murine model and determine the 
relationship between cyclic wall strain and IH. 
1.2 Overall goal and hypothesis 
The overall goal of this study is to determine the relationship between cyclic wall strain and 
IH in a small animal model of arterial occlusive disease. We hypothesize that reductions in 
oscillatory wall strain precede the formation of intimal hyperplasia in a murine model 
(Figure 1-2). The expected outcome of this dissertation is to provide compelling evidence to 
support the above hypothesis and to enable future research to establish if mechanical strain can 
be used to predict IH formation in the mouse or in larger animals.  
To systematically test our hypothesis, this dissertation was divided into three specific aims 
and 5 objectives. Herein, we first aim to develop and validate a novel, high spatial and temporal 
resolution method for measuring cyclic wall strains in the murine model. We then aim to 
demonstrate that a relationship exists between cyclic strain and IH. Finally, we aim to 
determine the detailed temporal changes in both cyclic strain and IH and demonstrate that 
changes in cyclic strain precede IH formation in this model. 
5 
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Figure 1-2: Overall hypothesis of this dissertation.  We hypothesize that, using a murine model of IH, we can 
demonstrate that reductions in cyclic circumferential wall strain temporally precede the formation of IH in the 
corresponding region of the vessel. 
1.3 Specific Aim I: Develop and apply a noninvasive, ultrasound-based 
method for measuring mechanical strain in the murine vasculature 
Recent developments in high frequency ultrasound technology have considerably improved 
both the spatial and temporal imaging resolution of ultrasonography systems, allowing 
researchers to accurately measure luminal diameter in vivo in mice.38, 39 Simultaneously, 
improvements in speckle tracking technology in ultrasound imaging has allowed for objective 
quantification of both myocardial strains and strain rates in small animal models.40-43 In this 
Aim, we propose that the combination of high frequency ultrasound and speckle tracking 
algorithms can be used to quantify and assess mechanical strains on the murine arterial wall in 
vivo. 
6 
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1.3.1 Objective 1A:  Validate an ultrasound-based strain measurement 
technique 
A number of measurement techniques have been applied to measuring strains on the 
arterial wall both in vitro and in vivo. Given that we eventually aim to apply our strain 
measurement technique to an in vivo murine model, the technique must be both noninvasive 
and have a large enough spatial resolution to resolve changes in diameter of vessels on the 
micron scale.40 High frequency ultrasound meets both of these requirements. In this objective, 
we used telecentric optics to accurately and dynamically measure the diameter of an in vitro 
murine artery phantom. Simultaneously, we measured strains using our novel ultrasound-
based method and demonstrated that we produce similar results with both techniques. 
1.3.2  Objective 1B: Apply the ultrasound based method in vivo in a murine 
model of vascular disease 
Although IH remains the overall focus of this study, the development of a non-invasive, 
high resolution strain measurement method for in vivo studies would be beneficial to the study 
of a number of vascular diseases. In this objective, we chose to apply our novel ultrasound 
technique to a murine model of abdominal aortic aneurysm (AAA) formation. In this objective,  
we hypothesized that high-frequency ultrasound scan biomicroscopy combined with speckle-
tracking can be used to define the role of oscillatory wall strain in AAA formation in defined 
aortic anatomic regions in the Angiotensin II apolipoprotein-E deficient mouse model of AAAs. 
The results of this objective demonstrate the utility of our novel ultrasound method and showed 
that it can be effectively applied to mouse models of arterial disease.44 
1.4 Specific Aim II: Evaluate if a relationship exists between oscillatory 
wall strain and intimal hyperplasia formation 
In Specific Aim I, we validated the measurement accuracy and precision of our ultrasound 
strain measurement technique and demonstrated that it can be effectively applied to a living 
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model of arterial disease. In Aim II, we apply this method to a novel model of arterial intimal 
hyperplasia and examine how dynamic mechanical strain relates to IH.  
In a previous study in our collaborating lab, we have demonstrated a novel, technically 
simple, model of IH formation in the mouse.37 In this model, a focal stenosis is created on the 
murine carotid artery. In the resulting publication detailing this method, we showed that 
immediately after creation of the focal stenosis, wall shear stress and cyclic wall strain were 
significantly reduced in the artery proximal to the stenosis. In objective 2, we combine this novel 
model with our ultrasound-based strain measurement method to better understand the 
relationship between cyclic strain and IH formation in the mouse. 
1.4.1 Objective 2:  Determine what relationship exists between mechanical 
strain and pathological wall remodeling 
In order to assess the relationship between IH and cyclic strain, in objective 2 we used the 
ultrasound strain measurement technique validated in Aim I to assess cyclic strains in the 
region proximal to the stenosis pre-operatively and at day 27 after focal stenosis. We then 
collected arterial tissues for histological analysis at day 28.  In this objective, we demonstrate 
that when we create a focal stenosis in our mouse model, we induce the formation of IH and the 
complete occlusion of ~30% of arteries by 28 days post-surgery. In this objective, we discovered 
that there was a relationship between cyclic strains measured at day 27 and IH at day 28.  The 
existence of this relationship suggests that changes in mechanical strain may play an underlying 
role in the processes that eventually result in IH formation. 
1.5 Specific Aim III: Determine if changes in oscillatory wall strain 
precede formation of intimal hyperplasia in vivo 
In Specific Aim II, we provide evidence that a relationship exists between acute changes in 
mechanical strain and IH formation at the ~1 month time point in our murine model. In the final 
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objective of this dissertation, we seek to more clearly define this temporal relationship and to 
delineate exactly when both cyclic strain and IH formation occur in this model 
1.5.1 Objective 3A: Determine the temporal progression of wall strain in the 
focal stenosis model 
In the objective 3A experiment, we use data collected from the animals in Objective 2 to 
assess changes in strain at just 4 days post-op. Regional reductions in oscillatory wall strain 
were quantified at day 4 and compared to histological outcome at day 28. Relationships 
between early changes in mechanical strain and eventual IH  
1.5.2 Objective 3B: Determine the temporal progression of intimal 
hyperplasia in the focal stenosis model 
In objective 3B, we will use and additional in vivo study in our mouse model of intimal 
hyperplasia. In this study, IH was assessed just 4 days after creation of the focal stenosis to both 
validate that strain reductions occur and to determine if morphological changes or IH are 
visible at day 4. 
9 
Chapter 2: Background 
2 Background 
2.1 Introduction 
2.1.1 The cardiovascular system 
The cardiovascular system serves as the primary nutrient and waste transport system in the 
body. It is responsible for carrying oxygen, nutrients and hormones to the body’s tissues and 
removing carbon dioxide and other wastes. The cardiovascular system is composed of two 
primary components: the heart and the blood vessels. The heart is an electromechanical pump 
which continually beats throughout a person’s life. With each beat, the heart creates pressure 
gradients which in turn force blood into the vascular system.45 
The vascular system is a system of tubular blood vessels which transfer blood to and from 
the body’s tissue with each heartbeat. Although often simplified and considered a system of 
pipes that transports blood, the vasculature is a complex, living and changing system that varies 
considerably in the body in different anatomic locations. Blood vessels are composed of three 
different layers, each of which functions to maintain vascular homeostasis.  
2.1.2 Vascular structure 
The outermost layer of the blood vessel is the adventitial layer. This layer primarily 
functions to reinforce the vessel and to anchor it to surrounding tissues. The adventitia is 
composed mostly of interwoven collagen fibers and is infiltrated with fibroblasts.46  The high 
collagen content of the adventitia plays a role in preventing vascular rupture at high 
pressures.47 Additionally, in larger blood vessels, the adventitia can contain a network of 
smaller blood vessels (the vasa vasorum) which supply nutrients to the vessel wall, which is too 
distant to obtain nourishment from the vessel lumen.45 The vasa vasorum is seen primarily in 
larger mammals and is not found in small mammals such as mice.46  
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Just inside of the adventitial layer is the external elastic lamina, which is a fenestrated, 
circumferentially oriented sheet of elastin. Throughout the medial layer of the blood vessel, 
these elastic laminae occur alternately in the radial direction with layers of vascular smooth 
muscle cells (SMCs) and proteoglycan rich extracellular matrix (ECM).46 Thin fibers of elastin 
intersect the SMC layers connecting the lamina and forming a continuous three dimensional 
network throughout the vessel.48  Although the number of lamina in the arteries of a given 
animal may vary greatly throughout the vascular system, the average tension per lamellar unit 
falls into a surprisingly narrow physiological range, suggesting that lamellar tension is 
physiologically maintained across vessels of different sizes and even across many mammalian 
species.32, 49, 50  This concept is further supported by studies demonstrating that removal of SMC 
function in the adult artery does not reduce the static mechanical properties of the vessel.51 This 
suggests that the mechanical properties of the vessel are mainly due to the collagen and elastin 
fibers in the media and are not due to SMC muscle tone.46 
On the inside of the innermost elastic lamina, or internal elastic lamina, is the intimal layer 
of the blood vessel. In the healthy artery, the intimal layer is typically formed of a monolayer of 
endothelial cells which produce and attach to a basal lamina that is supported by the internal 
elastic lamina.46 In some larger animals, including humans, the healthy intimal layer also 
contains some SMCs in addition to the underlying basal lamina.52-54  Although the intimal layer 
does not contribute significantly to vascular mechanics,55-57 it does play an important role in 
maintaining vascular homeostasis. The intimal layer forms a barrier between the blood and the 
underlying basal lamina. Denudation of the endothelial layer results in local protein adsorption 
from the blood stream and can eventually result in thrombosis. In addition to its barrier 
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function, the intimal layer also plays an important role in mechanosensation of flow through the 
blood vessel and provides molecular cues that control SMC tone in the medial layer.58-61 
The layers of blood vessels can be clearly observed using histological staining techniques 
and biomicroscopy. Masson’s trichrome stain differentiates the layers of the arterial wall clearly 
by staining the elastic lamina bright red, the vascular smooth muscle cells red, the collagenous 
fibers in the adventitia blue and the nuclei black. Figure 2-1 shows a Masson’s Trichrome stain 
of the healthy murine carotid artery. Although all blood vessels are composed of adventitial, 
medial and intimal layers, the size and structure of these three layers vary considerably 
throughout the vascular system. The vascular system can be broadly divided into 3 separate 
types of blood vessels: arteries, capillaries and veins. Arteries are the first conduits in which 
blood travels as it exits the heart. Arteries are typically large, muscular vessels which are 
conditioned to withstand the high, pulsatile pressures created by the beating heart. The largest 
artery, the aorta, is the first vessel which comes off of the heart. As blood travels through the 
vasculature from the heart, it is branched into arteries and arterioles, which eventually branch 
into capillaries. Capillaries are typically formed of only a monolayer of endothelial cells and 
allow for nutrient transport to the surrounding tissues. After leaving the capillaries, blood flows 
into the venules and then into the larger veins before returning to the heart. Given that blood 
pressures and flow rates through the different types of blood vessels differ considerably 
throughout the vascular system, the relative compositions of the three different vascular layers 
also vary by vessel type.   
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Figure 2-1: Structure of the healthy artery.  (A) Schematic of the different layers of the blood vessel. (B) 
Masson’s trichrome stain of a full carotid arterial cross-section in a healthy adult mouse carotid artery. (C) A high 
magnification image of the arterial wall showing the internal (black arrow) and external (green arrow) elastic 
laminae. (D) Immunohistochemical stain of a full mouse arterial section stained for endothelial lining (CD-31, red), 
smooth muscle cells (myosin heavy chain, green), and nuclei (Hoechst 33342, blue) L represents the vessel lumen, M 
represents the medial layer and A represents the adventitial layer. (E) 100x magnification image of vessel wall from 
D.  
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2.1.3 Mechanical forces on the vessel wall 
In addition to having a structure targeted at withstanding mechanical forces in their 
respective locations in the body, many blood vessels also actively react to changes in blood 
pressure and flow to maintain homeostasis. In particular, blood vessels have been shown to 
sense and react to two different forces: hemodynamic luminal shear stress and wall tensile 
stress. Figure 2-2 shows the major forces applied to the blood vessel.  
Hemodynamic shear stress is the shear force applied to the endothelial cells in the vessel 
lumen by the flow of blood through the vessel and can be computed using Equation (2-A). The 
majority of research assumes that the blood has a constant viscosity and therefore can be 
considered as a Newtonian fluid.62-69  
 (2-A)  
Using advanced mechanical modelling techniques, the non-Newtonian properties of blood 
can be included in shear stress analysis. These techniques demonstrate that Newtonian 
assumptions can grossly underestimate average wall shear stress on the wall and overestimate 
the maximum shear stress.70 Despite this evidence, limitations in data available in most in vivo 
studies force most researchers to continue using Newtonian fluid assumptions. 
 Vascular endothelial cells are equipped to sense and respond to the luminal shear forces 
applied to them. A number of cell surface receptors, ion channels and the cell cytoskeleton have 
been shown to specialize in mechanotransduction of wall shear.71 Under normal physiological 
conditions, steady laminar blood flow generates, on average, a shear stress of approximately 15 
dynes/cm2.72 When sensing this physiological level of shear, endothelial cells release nitric oxide 
𝜏 𝑢 = 𝜇
𝑑𝑢
𝑑𝑦
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and other chemical mediators which maintain medial SMCs in a quiescent state and promote 
vasodilation of the vessel wall.73  
Similarly to hemodynamic shear stress, tensile stress in the vessel wall has also been shown 
to be maintained homeostatically in the healthy artery.74 Tensile stress is most simply defined as 
the force per unit cross-sectional area acting on a given surface. In three dimensions, stress is 
represented as a 2nd order tensor with 6 independent stress components representing the force 
per unit area on the sides of a volume element. In the arterial wall, this tensor is typically 
defined in cylindrical coordinates with 3 normal components and 3 shear components. The 
normal components of arterial stress are circumferential (σθθ), longitudinal (σll), and radial (σrr) 
stress and the shear components are σrθ, σlθ, σlr. (Normal stresses are shown in Figure 2-2) 
Under a given mechanical stress, the blood vessel will deform until the forces within the vessel 
reach equilibrium. 
Mechanical strain is a measure of the distortion of the vascular wall. Although there are a 
number of mathematical definitions of strain,75 the most commonly used definition in the 
literature for blood vessels is the Green (Lagrangian) strain tensor. For this reason this 
definition will be used throughout the rest of this dissertation. Like wall stress, strain is also a 
2nd order tensor with 6 independent components. Strains in the vessel wall due to the internal 
blood pressure are limited to the strains in the normal directions: radial strain, longitudinal 
strain and circumferential strains. Although others have assessed radial76 and longitudinal77 
strains, experimental data77 shows that circumferential strains in blood vessels are larger than 
the other strain components. For this reason, we focus solely on circumferential strains for the 
remainder of this dissertation.   In Green’s definition of strain, the deformation of a body is 
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determined as the change from a reference configuration to a final configuration using the 
starting configuration as the reference point. Optimally, the reference configuration for strain is 
defined as the point where the body is under no stress. Defining this configuration in the artery 
is complicated by the fact that arteries under no external forces still having residual stresses 
internally.78 This is further complicated in vivo where the external forces (i.e. blood pressure) are 
never zero. Therefore, in this dissertation, we will measure oscillatory wall strain. This strain is 
defined using the vessel at diastole as a reference configuration and the vessel at systole as the 
final configuration. Although this definition provides no information about the absolute strain 
state of the vessel wall, it does measure how much strain is being applied to the vessel wall 
cyclically with each cardiac cycle and is easily measured in vivo. 
Since wall stress and wall strain are intimately related through the mechanical properties of 
the vessel wall, wall strain has consequently been implicated as a mediator of vessel 
homeostasis in addition to wall stress. 33, 79 In vitro studies have demonstrated that both vascular 
SMCs and vascular endothelial cells respond to changes in cyclic stress/strain independently of 
wall shear stress.80 This suggests that shear stress and strain mechanosensation pathways 
independently contribute to changes in wall composition seen during neointima formation. 
Together with shear stress mechanotransduction mechanisms, the vascular wall is able to 
maintain a homeostatic level of internal pressure and luminal flow.  
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Figure 2-2: Forces applied to the blood vessel wall in vivo. The arterial wall is subjected to 4 primary forces in 
vivo: wall shear stress (τw, red arrows), longitudinal stress (σll, blue arrows), radial stress (σrr, purple arrows) and 
circumferential stress (σθθ, orange arrows). 
2.2 Vascular disease 
In this dissertation, we aim to unravel relations between vascular mechanics and intimal 
hyperplasia. In order to fully describe the importance of these relations, we must first examine 
the known relationships between vascular mechanics, IH and vascular disease currently 
described in the literature. In the following sections we will discuss these relationships. 
2.2.1 Relation between intimal hyperplasia and vascular disease 
Despite extensive research and funding, cardiovascular diseases remain the number one 
cause of death in first world countries.1 Although a number of pathologies underlie 
cardiovascular diseases, many pathologies begin with occlusion of the arterial lumen via 
arteriosclerosis. Pathologies affected by arteriosclerosis include myocardial infarction, stroke, 
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and many others.  Arteriosclerosis is characterized by the progression from intimal thickening, 
to inflammatory response, and finally to the formation of fatty streaks and atherosclerotic 
plaques.3 One of the major factors that initiates the formation of arteriosclerotic plaques is IH,3 
and a number of researchers have demonstrated that mechanical forces underlie the 
propagation of intimal hyperplastic lesions.14, 26, 81-85   
Intimal hyperplasia (IH) can be defined as the proliferation of cells in multiple layers 
internally to the internal elastic lamina. Further, IH cells are observed to express αSMA either 
permanently or temporarily.3  Others add that the term IH should be reserved for tissues that 
are both proliferative and without common orientation or clear organization. Cells in IH tend to 
be spread out with abundant matrix and few, if any, collagen or elastin fibers.13 Although IH is 
typically considered to be a completely pathological response, there are some cases in which IH 
occurs during healthy physiology. The most commonly referenced cases of this non-
pathological IH are the closing of the ductus arteriosus and the closure of umbilical arteries.86 
Others also report a benign form of IH in the healthy artery. This benign IH has a similar 
appearance to that of pathological IH but does not significantly reduce lumen area or flow.53, 54 
Given that the underlying causes of IH and the relation between pathological and benign IH 
remain unclear, the connection between IH and disease is an important field of study with 
widespread impact on vascular disease. 
In vivo, IH is a precursor and the primary underlying cause for a number of vascular 
diseases and the subsequent failure of many vascular surgical interventions. Atherosclerosis, 
the stiffening and stenosis of the artery due to plaque formation, has been shown to occur in 
regions of preexisting intimal hyperplasia.87 Atherosclerotic plaques can go on to cause luminal 
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narrowing, and eventually the total blockage of the arterial lumen.88 Blockage of blood flow 
results in distal organ ischemia, and eventually cell death. This IH-initiated pathway has been 
shown to contribute to a number of diseases including stroke,89 coronary artery disease,6, 86 
peripheral artery disease,90 and restenosis after a number of clinical interventions.6, 8, 13  The 
following sections of this dissertation will delineate the current literature that relates 
mechanical forces to biological outcome in intimal hyperplasia. 
2.2.2 Relation between Wall shear stress and vascular disease 
Blood flow through the healthy artery in vivo is typically laminar and maintains a time-
averaged shear stress on the vascular endothelial cells of 10-15 dynes/cm2 (1-1.5 Pascals).91 
Regions of low wall shear stress and oscillatory flow have been positively correlated with IH in 
vitro25 and in vivo,92 while high levels of laminar blood flow (shear stress) results in decreased IH 
formation.66 Additionally, increases in blood flow in vessels with preexisting IH can induce 
regression of IH.82  Although high blood flow is typically considered atheroprotective, 
extremely high shear stresses have also been associated with IH formation.93  
Given that, in the arterial circulation, shear stress constantly changes as the heart cycles 
between diastole and systole, it is necessary to clearly define what “low shear stress” means. 
Typically, low shear stress in the arteries refers to shear stress with a time average magnitude of 
less than about 10 dynes/cm2 92, 94 but can refer to larger or smaller values depending on the 
arterial conditions or species.59, 95 A number of in vitro studies have demonstrated that 
endothelial cells can sense and respond to changes in hemodynamic shear stress. Of the many 
biological changes caused by changes in hemodynamic shear stress, the most commonly cited is 
the nitric oxide (NO)/endothelial nitric oxide synthase (eNOS) pathway.59, 82, 96-103 In vitro, it has 
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been demonstrated that increases in applied shear stress results in increases in NO production 
in arterial endothelial cells.104 NO has also been shown to prevent vasoconstriction of vessels in 
the microcirculation suggesting that it both causes vasodilation and reduces the effects of 
vasoconstrictors.105 Colotti et al. demonstrated that treatment of IH-prone vessels with nitric 
oxide (NO) reduces IH production in an ex vivo model.106 Further, in vivo studies have 
demonstrated that local release of NO can reduce intimal hyperplasia in both the IH-prone 
artery and the stented artery.107, 108  
Although extensive research has demonstrated the importance of the NO/eNOS pathway in 
effecting vasodilation after changes in wall shear stress, the mechanism by which the 
endothelial cells actually sense shear stress still remains unclear.109 One hypothesis to date 
involves mechanosensation of fluid shear via torque applied to the endothelial glycocalyx. The 
glycocalyx is a carbohydrate rich layer of molecules that lines the outside of the cell 
membrane.45 A number of recent studies suggest that endothelial sensation of torque on the 
glycocalyx results in changes in cell membrane permeability which therefore results in release 
of NO molecules.109-111  
2.2.3 Relation between wall tensile stress and strain and vascular disease 
In addition to the wall shear stress applied to endothelial cells, the vessel wall is also 
cyclically exposed to mechanical strain and stress in both the circumferential and longitudinal 
directions with each cardiac cycle.112 Although mechanical strain is fundamentally different 
from mechanical stress, the close relationship between the two parameters makes it difficult to 
separate their effects.  
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 Although this stress is applied to the endothelial cells of the intima, the majority of the 
stress is supported by the SMCs of the medial layer. Although the exact mechanisms of stress 
mechanotransduction remain unknown, a plethora of research demonstrates that stress and/or 
strain mechanotransduction plays a role in vascular disease. Evidence shows that increases in 
intraluminal pulse pressure (and therefore stress and strain) result in compositional changes in 
the blood vessel wall. 50, 113 Additionally, excessive mechanical stretch can result in SMC 
hypertrophy,114, 115 localized inflammatory reactions and degradation of wall structural elastin 
and collagen.116 All of these changes could contribute to changes in wall structural properties. 
Reductions in mechanical stretch also yield changes in SMC phenotype. One study 
demonstrated that reducing circumferential strains applied to arteries in vitro resulted in SMC 
proliferation and increased production in inflammatory cytokines.117 These correlations suggest 
that vascular cells sense changes in both shear stress and tensile stress (and/or strain) and react 
to changes in their mechanical environment. 
Some research suggests that the arterial wall actively maintains a homeostatic level of wall 
stress.31, 59, 118 This theory is supported by the observation that the number of lamellar units in 
any given artery is proportional to blood vessel diameter across a number of mammalian 
species.32 By maintaining this relationship, the vascular wall keeps the mechanical tension per 
lamellar unit within an amazingly narrow physiological range.  
Compared to the well-established effect of shear stress, the impact of wall strain on the 
development of intimal hyperplasia is much less defined, and thus the focus of the current 
proposal. From a mechanical standpoint, the artery can be considered a composite structure 
with three mechanically unique layers. Given that the intima in the healthy artery is typically 
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only one cell layer thick, it is generally considered to not contribute to healthy arterial wall 
mechanics.119, 120 Previous studies have examined the different contributions of the arterial wall 
layers to wall mechanics in both the healthy120 and diseased arteries.121 These studies 
demonstrated that the material properties vary significantly amongst the three layers120 and that 
the mechanical properties of the intimal layer can contribute significantly to mechanical 
properties after pathological neointima formation has occurred.121 
Smooth muscle cells are the most prominent cell type in the blood vessel and therefore are 
the cells that are affected most by cyclic strains. A number of studies have demonstrated 
relationships between oscillatory strains and biological changes in vascular SMCs. In vitro 
studies have demonstrated that oscillatory strains result in increases in SMC synthesis of 
collagen122-124 and elastin as well as glycosaminoglycans (GAGs) such as versican and hyaluronic 
acid.14, 80, 125 Further, studies have shown that the magnitude of ECM and GAG synthesis by 
SMCs are dependent upon strain magnitude, strain frequency and time in culture. 80   Recent ex 
vivo studies have proposed that mechanical strain works independently of the wall shear stress 
to cause intimal hyperplasia.126, 127 Cyclic strain has been shown to cause structural and 
compositional changes in both the endothelial and smooth muscle cells of vein grafts.128, 129 
Evidence in vivo suggests that wall strain correlates positively with intimal thickening.73, 130 In 
the cell culture setting, mechanical stretch activates several pathways capable of regulating 
smooth muscle cell phenotype,131, 132 but biologic information in the in vivo setting is limited. 
This dearth of mechanistic knowledge into links between strain and intimal hyperplasia is 
largely the result of limited capabilities in the measurement of strain in the intact animal. 
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2.3 Techniques for measuring vascular mechanics in vivo 
Although a large quantity of research has been completed to characterize in vitro cellular 
reactions to mechanical stresses and strains, true clinical relevance is best realized through in 
vivo research in animal models and in the clinic. A major hurdle that must be overcome is the 
need to accurately and consistently measure mechanical stresses and strains in vivo. Optimum 
measurement of mechanical stresses and strains in vivo would include non-invasive approaches 
that have limited effects on animal physiology. The problems associated with in vivo studies are 
exacerbated in small animal models of vascular disease, such as the mouse, because of the small 
size of rodent vasculature. In this section, we will discuss different methods that are used to 
measure mechanics in vivo in both animal models and humans 
2.3.1 Measurement of wall shear stress 
Wall shear stress measurements in vivo are typically made using either MRI or ultrasound-
based of blood flow through the blood vessel. Ultrasound approaches use either transit time of 
an ultrasound pulse through the vessel to determine bulk blood flow velocities133 or use the 
Doppler effect to determine local average blood velocities134. Others utilize phase-contrast MRI-
based measurements to estimate wall shear stress from flow rates.135 Of these two methods, 
ultrasonography provides both higher spatial and temporal resolutions.136  
The simplest approach to measuring flow velocities using ultrasonography is the use of 
transit-time flowmeters to measure bulk flow through the blood vessel. Transit-time flowmeters 
are limited in that they require that the vessel be exposed in order to measure the flow through 
the vessel. From bulk flow measurements, it is possible to estimate shear stress at the vessel 
wall using equation (2-B) below where τ is shear stress, μ is the dynamic velocity of blood, Q is 
the volumetric flow rate, and d is the vessel’s diameter: 
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   (2-B) 
 
This formula assumes that the blood has a fully developed, laminar and parabolic flow 
profile. Additionally it assumes that the blood has constant dynamic viscosity (typically ~3.3 
cP)37 and that the vessel has a constant, circular cross-section. Although these assumptions may 
be accurate enough to calculate time average shear stresses in a healthy blood vessel, they vastly 
underestimate the shear stresses due to pulsatile flow and non-laminar flow profiles. 
Continuous wave Doppler ultrasound has been used extensively to quantify changes in 
blood flow in humans for over 30 years.137-139 This approach, based on the Doppler Effect, 
continuously transmits and receives sound waves through the blood vessel wall. The frequency 
shift of the sound waves received by the transducer compared to those sent are related to the 
velocity of blood flow through the vessel. The primary limitation of this approach is that it 
provides no information about where in the ultrasound field of view the measured flow is 
occurring. Additionally, it is not possible to simultaneously measure continuous-wave 
ultrasound data and collect ultrasound images, making it even more difficult to interpret flow 
measurements.  
In order to overcome some of the issues associated with continuous-wave Doppler 
ultrasonography, pulsed-wave Doppler ultrasonography was developed. Pulsed wave Doppler 
ultrasonography differs from continuous-wave ultrasonography only in that brief pulses of 
ultrasound wave are emitted.  Based on the timing of these pulsed waves and the known speed 
of sound in tissue, pulsed-wave Doppler made it possible to determine the location of flow 
velocities. This finding also allows for the use of duplex ultrasound where Doppler velocity 

32 Q
 d
3

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flows and B-mode ultrasound images are simultaneously collected. Even with pulsed-wave 
Doppler ultrasonography, the method by which shear stress is calculated is limited by a number 
of assumptions. With both pulsed-wave Doppler, wall shear stress is typically computed based 
on the maximum velocity (Vmax): 
 (2-C) 
 
This formula once again makes the same assumptions as that used for transit-time 
flowmeters. As a result, it is prone to substantial errors that may cause it to underestimate 
differences in regional shear stress. 140 Despite these limitations, a number of clinical studies 
utilize Doppler ultrasound shear stress calculations for both research and diagnosis.141-143 
2.3.2 Measurement of wall tensile stress 
Unlike hemodynamic shear stress, tensile stress in the vascular wall cannot be measured 
based on blood flow. Rather, the most relevant physical method of estimating tensile stress in 
the vascular wall is through use of pressure measurements. The most simplistic approach to 
estimating wall stresses is the use of Laplace’s law and assuming the artery is a thin walled 
cylindrical pressure vessel with constant thickness and homogeneous mechanical properties.36, 
144 To better estimate wall stresses, it is often necessary to constitutively model the blood 
vessel.78, 145 Although constitutive modelling is not a direct method of measuring wall stresses in 
vivo, it can be made to be patient specific by combining 3D imaging (such as MRI or CT scans) 
with blood pressure measurements. Combining these two measurements into one computer 
model can provide data about mechanical stresses for a specific artery. 146, 147 Given that 

4  Vmax
d
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computational modelling is time consuming, and requires that a number of assumptions be 
made about arterial mechanics,145 it may not be the best in vivo measure of wall mechanics.  
2.3.3 Measurement of wall strain 
Wall tensile stress is directly related to tensile strain in the vessel wall through the 
mechanical properties of the arterial wall. Given that a number of studies have demonstrated 
that the mechanical properties of the arterial wall can be changed in the diseased state,55, 148, 149 it 
is reasonable to assume that there will be changes in in vivo wall stresses and strains due to 
changes in wall mechanics. Relative to measuring wall tensile stresses in vivo, measurement of 
wall strains is comparatively easy. In order to measure wall strains, it is generally necessary to 
define a zero strain state from which strains will be measured. Ideally, the zero strain state 
would be defined with the vessel under zero pressure. Since it is not possible to measure the 
arterial diameter under zero pressure in vivo, the zero strain state for most in vivo studies is 
typically defined as the state of the vessel at diastole.150  
A number of approaches have been used to measure wall strains in vivo. In humans, MRI, 
and both external and intravascular ultrasound have all been used to estimate oscillatory wall 
strains.148, 150-152 MRI has been used in humans to measure circumferential strains in both the 
carotid artery 153 and the descending thoracic aorta.154 Others have reported using MRI to 
measure carotid strains in the mouse, but EKG gating must be used to overcome temporal 
resolution limits.35 
Ultrasound has been used in humans to assess mechanical strains in a number of studies. In 
the majority of these studies, speckle tracking algorithms are applied to longitudinal B-mode 
images of arteries and displacements in each direction are computed. From these displacements, 
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average strains can be determined.150 Use of longitudinal B-mode views provides robust data 
for accurate calculation of average strains but does not allow for regional strain measurement. 
Others have used external ultrasound to measure cross-sectional diameters in humans and 
estimate strains based on diameter changes.155 Use of cross-sectional ultrasound images allows 
for the measurement of circumferential strains in a specific arterial region but is hindered by 
changes in probe angle. 
In rodents, measurement of vascular strains is more difficult due to the small size and fast 
heart rates of mice and rats. These conditions require methods with significantly higher spatial 
and temporal resolutions then is necessary in humans. Goergen et al. reported using MRI to 
measure aortic strains in the mouse with sufficient spatial resolution and using EKG gating to 
overcome temporal resolution limits.35 Others have reported using longitudinal ultrasound 
images to measure strains in the mouse. 156 Newer ultrasound systems used primarily in the 
cardiac literature now report spatial and temporal resolutions that are sufficient to accurately 
image cardiac cycles in the mouse.40, 157 As discussed in section 
2.4 Summary 
A plethora of studies have demonstrated that vascular cells respond to changes in their 
mechanical environment46, 126, 128, 158, 159 and that these changes in mechanical environment can 
induce pathological changes in the vessel wall.36, 121, 155, 160 Although the majority of previous 
work focuses on endothelial mechanosensation of wall shear stress25, 83, 93, 98, 100, 101, 161-165, evidence 
suggests that changes in wall shear stress alone do not fully explain the phenomenon of 
neointimal formation.27, 28  Herein, we focus on the relationship between cyclic deformation of 
the arterial wall and the eventual intimal hyperplastic outcome in a murine model.  By defining 
27 
Chapter 2: Background 
a relationship between noninvasively determined oscillatory wall strains and intimal 
hyperplasia, we will develop a better understanding of how changes in arterial mechanical 
environments relate to vascular disease.
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3 Objective 1A: Validation of ultrasound strain measurement 
3.1 Introduction 
Ultrasound has emerged as a tool to enhance understanding of vascular diseases in both the 
clinical166, 167 and research setting.168-172 One of the most commonly employed models is the 
murine model, due to its well-defined genome and relatively low cost.  Recently, high-
frequency ultrasound imaging systems (e.g. Vevo 2100, FUJIFILM Visualsonics, Toronto, ON, 
Canada) have been developed to noninvasively micro-image mice in vivo, and such approaches 
can reliably detect and measure the mouse aortic diameter in vivo.38, 39  At the same time, 
speckle-tracking technology in ultrasound imaging has emerged as a quantitative, objective 
technique to accurately evaluate myocardial function and dynamics. Speckle tracking functions 
by tracing the displacement of speckles during the cardiac cycle to measure strain and strain 
rate,40-43 and it has been used in the assessment of mouse models of cardiac dysfunction.173 In 
this chapter, we aim to validate a novel system for measuring wall strains noninvasively using 
an in vitro phantom model. 
A number of previous studies have employed in vitro phantoms of the artery to test novel 
ultrasonic measurement methods for both flow and a number of vascular disease analyses.150, 174-
177 Although these different phantoms vary in complexity, the simplest of them are composed of 
a piece of tubing suspended in a hydrogel solution. A pressure gradient or cyclic flow 
waveform is created within the tube which can be used to evaluate the ability of ultrasound to 
measure flow or other properties within the vascular phantom. More complex phantoms 
include highly sophisticated pulsatile flow pumps and harvested blood vessels with real blood 
flow through the lumen. Since the goal of this objective is to demonstrate that ultrasound strain 
measurements using our novel approach have similar results to those found using other 
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methods, we will use an extremely simple silicone tube model of a blood vessel with precisely 
defined dimensions. 
To provide a benchmark measurement for the strains measured using ultrasound, we will 
employ a high speed camera system with telecentric lenses to simultaneously measure the 
strain of the tube. Telecentric lenses are widely used in machine vision to measure the 
dimensions of products during manufacturing. In a typical camera lens system, the 
magnification of the system is modified significantly due to changes in focus setting178 and 
distance of the lens from the object.179 This property of traditional camera lenses can distort 
images recorded with a camera causing images to inaccurately represent the size of objects in 
the camera field.180 One approach to overcoming lens distortion is to use telecentric lens 
systems. Telecentric lenses create nearly orthographic projections of objects being imaged in the 
image plane. This means that objects that are in focus and those that are out of focus will still be 
projected at their actual size. Telecentric optics creates a distinct advantage in optical 
measurement methods because they minimize measurement error due to the perspective 
distortion. In conjunction with telecentric lenses, we used high density mapping (HDM), an 
optics-based measurement approach that we previously developed to determine regional 
displacements in a number of biological tissues.37, 181-183  In this objective, we will first 
demonstrate the accuracy of HDM by comparing HDM strain measurements with 
sonomicrometry, then validate our ultrasound-based method against HDM.   
3.2 Materials and methods 
3.2.1 Validation of High Density Mapping against sonomicrometry 
Sonomicrometry has long been considered a gold standard for distance measurement in 
medical displacement and strain analyses.184 To test the ability of HDM to measure strains, two 
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sonomicrometry crystals were attached to a 2 inch piece of ¼ inch I.D. Penrose tubing (Penrose 
drain, Cardinal Health, McGaw Park, IL). This tubing was attached to a syringe pump and 
oscillatory pressure gradients were created in the closed system to simulate oscillatory wall 
strains. Displacements were simultaneously measured via two 2mm sonomicrometry crystals 
sutured to the tubing surface (Triton, San Diego, CA) and a high speed camera (Fastcam 
1280pci, Photron USA, San Diego, CA) connected to a telecentric lens (486mm precision 
telecentric lens, Computer Optics Inc., Hudson, NH). Displacements from the optics system 
were computed using HDM181 and oscillatory wall strains were computed using both methods. 
Average strain magnitudes across several cycles were calculated. Simultaneously recorded 
strains from the cycles were compared using a paired t-test. A sample image used for HDM 
analysis is shown in Figure 3-1. 
 
Figure 3-1: Comparison of sonomicrometry and HDM strains. Two sonomicrometry (sono) crystals were 
sutured to the wall of Penrose tubing. HDM speckle tracking was used to simultaneously determine strains. 
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3.2.2 Development of an in vitro model of pulsatile pressure 
Given that ¼ inch Penrose tubing is much larger than the size of blood vessels analyzed in 
the remainder of this dissertation, ultrasound-based measurement of strain was validated using 
a small diameter silicone tube. Given that the smallest available sonomicrometry crystals are 
larger than our tubing phantom, validation of ultrasonography was completed using HDM and 
not sonomicrometry. In order to complete this validation, we first aimed to create an in vitro 
model of arterial pulsatile pressure. Using similar methodology to previous ultrasound vascular 
phantoms,150, 174-177 a small diameter (1.473 mm I.D.; 1.956 mm O.D., SMI Manufacturing, 
Saginaw, MI) silicone tube was securely attached to two 1/8 inch barbed connectors. One side of 
the tubing was connected to a 60 mL syringe (Figure 3-2). The tubing was cleared of air bubbles 
and the system was closed using a luer valve. The tubing was speckled using a 50:50 mix of 
silicon carbide microparticles (Silicon carbide 400 grinding compound, Alfa Aesar, Ward Hill, 
MA) and reflective paint (Scotchlite Reflective Ink 8017, 3M, St. Paul, MN) to create a unique 
light intensity distribution across the tubing surface. The tubing was secured to a custom optics 
rig and covered with optically clear ultrasound gel (Aquasonic Clear, Parker labs, Fairfield, NJ). 
A large glass coverslip was pulled back against the ultrasound gel and bubbles were removed 
using cotton swabs yielding a flat, undistorted view of the tubing. A telecentric lens and camera 
were then attached to the optics rig and the camera axis was aligned perpendicular to the 
coverslip. 
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Figure 3-2: Ultrasound validation experimental setup. A telecentric lens attached to a high speed video camera 
was used to make diameter measurements on a murine blood vessel-sized tube in vitro. Simultaneously, strains were 
measured using the proposed ultrasound measurement system. The resulting circumferential strains were compared 
between the two measurement methods. 
The 60 mL syringe was then connected to a syringe pump and controlled via a computer 
running pump system software (New Era pump systems, Farmingdale, NY). Cyclic strains were 
applied to the tubing wall at flow rates of 6, 8, 10, 12, 14 and 16 mL/min for periods of 1, 1.5, 2, 
2.5 and 3 seconds. While running each protocol, both ultrasound and video data were 
simultaneously recorded as described below. 
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Figure 3-3: Close-up of ultrasound validation tubing setup.  A large glass coverslip is used to create an 
optically flat surface behind which resides the ultrasound gel. This allows for clear, undistorted imaging of the tubing 
wall which has been pre-speckled to create a large light intensity distribution. 
3.2.3 Ultrasound data acquisition and analysis 
A 700 MHz ultrasound probe (MS700) and FUJIFILM Visualsonics Vevo2100 ultrasound 
system were used to record luminal wall strains within the tube. The ultrasound transducer was 
placed in the ultrasound gel and the tube lumen was visualized and brought into focus. Several 
consecutive cycles were recorded at a frame rate of 300 Hz. Cyclic mechanical strains as 
measured at the lumen of the vessel using Green’s definition were calculated and reported. 
Given that strains measured via ultrasound are 1 dimensional only, the stretch ratio was 
computed and green’s strain was calculated via equation (3-A). Cumulative Green’s strains 
were computed for each cycle and averaged for at least 5 cycles in each dataset 
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         (3-A) 
3.2.4 Video data acquisition and analysis 
A digital camera (EOS 7D, Canon USA, Melville, NY) was attached to the telecentric lens 
and the tubing was brought into focus. Videos were recorded at maximum resolution and 30 
frames per second simultaneously with the ultrasound system. High Density Mapping, a 
speckle tracking program previously developed in our lab along with custom MatLab programs 
was used to calculate strains on the outside of the vessel using Green’s definition.78, 181 Briefly, 
HDM uses a phase correlation algorithm in 2 dimensions to efficiently determine displacements 
of regions of an image. As seen in Figure 3-4, small 16 by 16 pixel size sub-regions are compared 
between two sequential images and combined via phase correlation in the Fourier domain. 
After subsequent application of an inverse Fourier transform, it is possible to determine the 
pixel level displacement of the region. Using the sub-pixel algorithm first described by Foroosh 
et al..185, it is then possible to determine the displacement of the region with an accuracy of 0.09 
pixels and a precision of 0.02 pixels.181 This process is iterated across all sub-regions 
(overlapping by 8 pixels) and images in a dataset to produce displacement fields. From these 
displacement fields, the displacement gradient tensor is determined and cumulative green’s 
strain is computed (Figure 3-5). For this study, only the normal plane strain in the 
circumferential direction is reported. 
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Figure 3-4: Use of High Density Mapping to determine displacement fields. A) A region of interest is defined 
in an image and divided into 16x16 pixel sub-regions. B) Fast Fourier transforms of corresponding sub-regions of 
sequential images are computed. C) Phase correlation is applied to the two images in the Fourier domain and the 
inverse Fourier transform of the result is taken. D) The resulting 2D plot contains a peak at the pixel level 
displacement of the region. 
 
Figure 3-5: Computation of green's strain from HDM data. A) The displacement gradient tensor Uij is computed 
from HDM displacements. B) The deformation gradient tensor Fij is computed from displacement gradients (δij 
represents the Kroneker delta) C) Green’s strain tensor Eij is computed. D) Cumulative strains across consecutive 
frames can by computed by multiplying deformation gradient tensors using matrix algebra. 
3.2.5 Theoretical relationships 
Since commercially available tubing in the size range targeted in this study was limited, the 
tubing used herein had a considerably thick wall compared to its radius. For this reason, thin-
walled tubing mechanical assumptions could not be used. To better understand the expected 
relationship between strains measured on the inside wall of the tubing (ultrasound) and strains 
measured on the outside (HDM), the theoretical relationship was determined mathematically. 
3.2.6 Statistics 
Statistical analyses were executed using Sigmaplot 11 (Systat Software, San Jose, CA). The 
resulting ultrasound and image strains for each pump condition were compared using a 
Pearson product moment correlation. Statistical differences between sonomicrometry and HDM 
strains were determined using a paired t-test. Statistical powers are reported for all negative 
statistical results. 
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3.3 Results 
3.3.1 Comparison of sonomicrometry and optical strain measurements 
Mechanical strains generated on Penrose tubing wall by a syringe pump were 
simultaneously recorded via a high speed video camera and sonomicrometer. Strains computed 
using HDM (from the high speed video) and sonomicrometer were averaged across 7 cycles. 
Data are presented as mean ± std and statistical comparisons and a paired t-test yielded no 
significant difference between the two methods (p=0.39, Power: 0.05). The resultant strain 
values are presented in Figure 3-6. 
 
Figure 3-6: Simulated wall strains in Penrose tubing. Data show mean oscillatory wall strain as computed via 
sonomicrometry and high density mapping for 7 simultaneously recorded cycles. No significant difference between 
the two groups was seen using a paired t-test. 
3.3.2 Comparison of optical and ultrasound strain measurements 
Although strain measurements were recorded at 4 different flow rates for 5 different 
amounts of time, upon analysis, usable strain recordings were only found using HDM for the 8 
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combinations that produced the largest strains. Thus, data reported below is for flow rates of 10, 
12, 14 and 16 mL per minutes and flow times of 2.5 and 3 seconds only. For the selected 8 
combinations, clear strain curves were computed using both HDM and US. Sample regions of 
interest and curves for each method in Figure 3-7: Sample regions of interest and strain curves. 
Peak strains for corresponding recordings from both HDM and ultrasound were averaged 
across at least 5 cycles and plotted with ultrasound strain on the x-axis and HDM strain on the 
y-axis (Figure 3-8). 
 
 
Figure 3-7: Sample regions of interest and strain curves. A) Ultrasound region of interest showing tubing 
lumen with selected ultrasound tracing and resulting strain curve. B) HDM images with region of interest (red) sub-
image size (green square) and sub-image shift (blue square). 
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Figure 3-8: Comparison of wall strains recorded with ultrasound and HDM.  Note that strains measured with 
ultrasound were measured at the tubing lumen while strains measured with HDM were measured on the outer wall. 
Line indicates the linear regression of the data. 
As seen in Figure 3-8, strains measured via HDM were significantly lower than those 
measured with ultrasound. Despite this difference, comparison of the data from the two 
methods yielded a Pearson’s product moment correlation coefficient of 0.83. The indicated 
linear regression of the data resulted in a slope of 0.23 with the linear fit equation (3-B): 
 (3-B) 
3.3.3 Theoretical relationships between lumen and outside strains 
The tubing used in this study has a thickness that is almost 25% of its inner radius. As a 
result, it must be considered a thick-walled pressure vessel and its change in thickness cannot 
be ignored. Since pressures were not measured in this study, the most relevant relationship to 
our study is the relation of strain at the outer wall (experimentally measured using HDM) to 
luminal strain (experimentally measured by ultrasound). Since Green’s strain was implemented 
EHDM 0.23EUS 0.002=
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for all calculations, Equation (3-A), was used to calculate strain from stretch ratios with E 
representing Green’s strain and λ representing the stretch ratio. 
To determine the relationships between Green’s strain for the inner and outer walls, the wall 
cross-sectional area (and therefore volume) were assumed to be constant. This assumption 
yielded the relationship in Equation (3-C) where ro and ri respectively are the outer and inner 
radius before stretching and Ro and Ri are the outer and inner radii after distension: 
   (3-C) 
        
Given that the stretch ratio (λ) is the ratio of the radius after distension to the radius before 
distension, the following relation between inner and outer strains can be determined. A 
complete derivation of Equation (3-D) is described in Appendix C: 
 (3-D) 
Using this ratio, a theoretical strain relationship curve can be determined and compared to 
the actual data. This curve is shown in Figure 3-9 alongside the experimental data. The resultant 
theoretical relationship indicated that the strain measured via HDM is theoretically expected to 
be 0.57 times the strain measured with ultrasound. 
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Figure 3-9: Theoretical relationship between lumen and outside strains for silicon tubing. Data points show 
strain as measured experimental while the line shows the theoretical relationship. 
3.4 Discussion 
In this chapter, we aimed to validate our ultrasonography-based approach to measuring 
small diameter vascular strains against another method of measuring strains. In order to 
accomplish this objective, a simple in vitro ultrasound phantom of a blood vessel was 
constructed and placed in a system designed specifically to allow for simultaneous comparison 
of strains measured with two different methods. Due to our expertise and publication history in 
the field of optics-based strain measurements,37, 181, 183 we chose to use our high density mapping 
software to measure regional displacements on the outside of the tubing wall. To enhance this 
approach, telecentric optics were employed to minimize perspective distortion.  
To demonstrate the capabilities of our HDM-based strain measurement approach, HDM 
strains were directly compared to those measured via sonomicrometry, a method often used as 
the gold standard for displacement measurements.184, 186 Using ¼ inch diameter Penrose tubing, 
we demonstrated that no difference in oscillatory wall strain values was determined between 
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sonomicrometry and HDM. Due to the large size (2mm diameter) of available sonomicrometry 
crystals, we were unable to use sonomicrometry in a direct comparison with our ultrasound- 
based strain measurement approach. We therefore directly compared HDM with 
ultrasonography. 
The tubing strains that could be produced by our system were primarily limited by the 
amount of force that could be generated by our syringe pump and the high stiffness of small 
diameter tubing that was commercially available at the time of this study. As a result of these 
system limitations, the mechanical strains experimentally measured with both HDM and 
ultrasound in this chapter were extremely low (< 2.5%) and therefore much smaller than those 
expected in vivo, where reported values are 20-25%.35 Despite these limitations, the results 
presented in Figure 3-8 demonstrate a clear positive correlation between the data measured 
using the two methods with a Pearson’s correlation coefficient of 0.83. Although the data do 
correlate, the relationship observed was definitely not 1:1; with strains measured by HDM 
considerably less than those measured by ultrasound. In order to better understand the 
relationship we should expect between these two measurements, the theoretical relationship 
was determined by assuming constant tubing volume. By deriving and applying Equation 
(3-D), we demonstrated that the theoretical strains measured via HDM at the tubing wall are 
expected to be smaller than those measured by ultrasound. This theoretical finding supports the 
experimental findings found in this chapter.  
The second factor we suspect may have affected our measurements in this chapter is the 
lower limit of the spatial resolutions of both the ultrasound and optics based measurement 
systems. Since the methods used by the ultrasound system to measure displacements are 
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proprietary, it is not possible for us to determine the spatial resolution of the system. Using an 
image of a scale with known length, the imaged pixel size for the HDM measurements reported 
in this chapter is 28.6 μm. The region of interest that was used for HDM analysis was 64 pixels 
(1830 µm) tall. Given that the reported theoretical displacement accuracy of HDM is 0.09 
pixels181 (2.57μm in this study) , the smallest strain that can be accurately determined in this 
study is 0.14%. This strain level was calculated by dividing the smallest pixel displacement that 
can be measured by the 64 pixel region height. Since the strains measured via HDM in this 
chapter are very close to or below this value, the reported HDM measurements are likely not 
very accurate due to the system’s resolution limits. To overcome these limitations, other 
methods of measuring strain should be used in the future to validate our ultrasound-based 
measurement approach. One method that has been used increasingly in medical imaging 
recently is optical coherence tomography (OCT).187, 188 OCT uses the same principles as 
ultrasound imaging, but uses the optical reflective properties of tissues rather than the sonic 
impedance to determine represent the tissue. Given that the wavelength of light waves are 
significantly smaller than that of high frequency sound waves, the resolution of OCT can be as 
high as 1 μm and some systems have reported temporal resolutions greater than 1 kHz.189 
Future studies should utilize a higher resolution state-of-the-art, such as OCT, to more 
accurately validate ultrasound-based strains. 
Despite the limitations in the system used herein, the strains measured between the two 
methods correlate well and are on the same order of magnitude as the theoretical values. An 
improved testing system with the capability to produce larger tubing strains would likely yield 
an even better correlation between the two methods. Given that strain measurements made 
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using ultrasound used in the remainder of this dissertation will not be compared between 
measurement methods, the limited correlation demonstrated in this chapter shows that our 
ultrasound-based approach can provide usable measurements even when near its resolution 
limits. In the next chapter of this dissertation, we will apply our ultrasound system to in vivo 
measurement of arterial strains.
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4 Objective 1B: In vivo testing of ultrasound vascular strain methodology 
The introduction (starting with section 4.1.1), methods, results and discussion presented in 
this objective are published in the Journal of Vascular Surgery. These sections are reprinted 
from: The Journal of Vascular Surgery, 56(2), John T Favreau, Binh T Nguyen, Ian Gao, Peng Yu, 
Jacob Schneiderman, Glenn R. Gaudette, C. Keith Ozaki, “Murine ultrasound imaging for 
circumferential strain analyses in the angiotensin II abdominal aortic aneurysm model”, p. 462-
469, Copyright 2012, with permission from Elsevier (Appendix A). 
4.1 Introduction 
In Objective 1A (Chapter 3) of this dissertation, we aimed to demonstrate that ultrasound 
strain measurements can be used to measure strain, as validated with optical measurement 
techniques, in a small analog of a blood vessel. For Objective 1B, we aimed to test this system on 
a live, in vivo model of vascular disease. For this study, we chose to analyze strains in a murine 
model of abdominal aortic aneurysm (AAA). The mouse model was chosen primarily because it 
is extensively used in the study of the mammalian vasculature and the diseases that affect it.  
4.1.1 Aortic aneurysms 
Despite knowledge insights over the last decades, the molecular mechanisms of aortic 
aneurysmal disease remain obscure.  Beyond some known clinical risk factors, biomechanical 
forces contribute to abdominal aortic aneurysm (AAA) development, progression, and 
rupture.190-192  The composition and mechanical properties of AAAs are different from those of 
normal aortas,193 with AAAs being stiffer and less distensible than non-aneurysmal aortas. 
4.1.2 Murine models of aortic aneurysms 
Murine models have emerged as a tool to enhance understanding of aneurysms,169, 170 
though biomechanical studies have been limited in these models.  One of the most commonly 
employed models involves subcutaneous delivery of angiotensin II (Ang II) into apolipoprotein 
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E-deficient (apoE-/-) mice via an implanted osmotic pump.169, 194-197  Despite widespread clinical 
value, the use of longitudinal imaging in these aneurysm models remains scarce and under-
utilized because the small size of the animals make the quantification and characterization of 
AAA progression difficult and time-consuming.  Current methods for measuring aneurysm 
biomechanics and progression are simplistic in that they assess only the gross appearance of the 
aorta,198 the maximum diameter of the aorta in situ,199 or the luminal diameter ex vivo.200  To 
date, a few in vivo imaging studies have been done on small animal AAA models, but they also 
only measured aortic diameters.38, 201-203 Recently, high-frequency ultrasound imaging systems 
(e.g. Visualsonics Vevo 2100, Visualsonics, Toronto, ON, Canada) have been developed to 
noninvasively micro-image mice in vivo, and such approaches can reliably detect and measure 
the luminal diameter of AAA in apoE-/- mice infused with Ang II.38, 39  At the same time, 
speckle-tracking technology in ultrasound imaging has emerged as a quantitative, objective 
technique to accurately evaluate myocardial function and dynamics. Speckle tracking functions 
by tracing the displacement of speckles during the cardiac cycle to measure strain and strain 
rate,40-43 and it has been used in the assessment of mouse models of cardiac dysfunction.173 
4.2 Materials and methods 
4.2.1 Mouse model 
Male apoE deficient mice (B6.129P2-Apoetm1Unc/J) were purchased from the Jackson 
Laboratory (Bar Harbor, ME), maintained on a 12-hour light-dark cycle, and received water and 
assigned chow ad libitum.  All animal experiments were performed according to protocols 
approved by the Institutional Animal Care and Use Committee and complied with the Guide 
for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 85-
23, Revised 1996). 
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At 16 weeks of age, osmotic mini-pumps (Alzet Scientific Products, Model 1002, Cupertino, 
CA) loaded with Ang II (500-1,000 ng/min/kg) were sterilely implanted in the dorsal 
subcutaneous tissues under 1-2% isoflurane inhalant anesthesia with oxygen at 1 L/min, and 
wounds closed with absorbable sutures. 
4.2.2 Dietary perturbations 
All animals received a 10 kcal% fat standard chow diet after weaning (D12450B; Research 
Diets Inc., New Brunswick, NJ).  The normal chow group was maintained on this diet 
throughout the course of the experiment.  To study the effect of diet induced obesity on aortic 
wall elasticity, animals designated as high fat were pre-fed with a 60 kcal% fat western diet 
(D12492; Research Diets Inc.) 6 weeks prior to Ang II infusion and maintained on this diet 
during the study.  Table 4-A summarizes the experimental groups and the specific diets over 
time. 
Table 4-A: Experimental groups for Objective 1A 
Diet Age at Implant Ultrasound acquisition 
Normal Chow 
(10 kcal% fat) 
16 Weeks 
Preop, Day 3 (n=8) 
Preop, Day 14, Day 28 (n=10) 
High Fat 
(60 kcal% fat) 
16 Weeks 
Preop, Day 3 (n=6) 
Preop, Day 14, Day 28 (n=10) 
 
4.2.3 Study design 
High resolution ultrasonography was performed using a Vevo 2100 Imaging System with 
MS700 (30-70 MHz) and MS550D (22-55 MHz) linear array transducers (Visualsonics).  For short 
term study groups, data was collected before implantation (pre-op) and at day 3 after 
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implantation, while for long term groups, data was collected preoperatively, at day 14, and at 
day 28 after implantation.  Mice were anesthetized using 1-2% isoflurane inhalant anesthesia 
with oxygen at 1 L/min and animals were placed in supine position on a moveable, heated stage 
maintained at 37˚C.  Hair was removed from the abdomen and thorax using a depilatory cream.  
Warmed ultrasound transmission gel was applied to the ventral surface of the animal and the 
probe was positioned on a fixed stand perpendicular to the stage.  After adequate visualization 
of the aortic segments of interest, one hundred frame (at 240-270 frames per second) B-mode 
cine image sequences were then recorded over an average of 2-3 cardiac cycles.  Since aortic 
pathologies associated with Ang II infusion frequently occur at defined locations along the aorta 
(arch and suprarenal > infra-renal and thoracic), six different anatomic segments were chosen to 
allow for comparisons of mechanical strains at these locations (Figure 4-1). 
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Figure 4-1: Segments of interest analyzed in the thoracic and abdominal aorta.  Celiac trunk (CT), superior 
mesenteric artery (SMA) and renal arteries (RA).  The thoracic region = cross-section 5mm proximal to the CT; the 
supraceliac region = cross-section 1mm proximal to the CT; the paravisceral region = cross-section between the CT 
and SMA; and the juxtarenal region = cross-section 1mm distal to the SMA. 
Ultrasound cine loops collected during the imaging procedure were analyzed to calculate 
circumferential strains.  Cine loops were loaded into Vevostrain 2100 Advanced Cardiac 
Analysis Software (Visualsonics) and analyzed using the manufacturer’s cardiac speckle 
tracking algorithm.  A closed spline of 48 points was manually drawn around the edge of the 
vessel cross-section in the ultrasound image.  Accuracy of speckle tracking throughout the cine 
loop was verified visually.  If tracking did not pass visual inspection, splines were redrawn 
until adequate tracking was achieved.  The frame-to-frame displacements of each of the 48 
points throughout the cine loop were the output for strain analysis.  Additionally, 
representative frames from the ultrasound images were saved to allow determination of vessel 
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regions that did not have enough speckle contrast for adequate analysis (regions that 
correspond to renal artery branching or echogenic shadow artifacts) (Figure 4-2). 
 
Figure 4-2: Sample ultrasound image of an aorta.  Orange line indicates manually drawn spline. Green traces 
show the path of the tracking points (yellow) throughout several cardiac cycles.  The dashed red line indicates a 
region that has poor contrast (likely due to a branching vessel) and therefore poor tracking. These regions were 
dropped from the analyses to improve accuracy. Yellow scale bar is 1-mm in length. 
4.2.4 Strain calculation 
Displacements from the Vevostrain software were then downloaded into a custom MatLab 
(Mathworks, Natick, MA) program and analyzed to determine circumferential strain from 
displacements.  Strains were determined at each of the 48 points around the vessel.  
Circumferential strains were calculated using the definition of the Cauchy strain tensor for 
cylindrical coordinates Equation (4-A).75   
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Radii were measured by determining the distance from each point to the centroid of the 
points around the vessel.  It was assumed that the local radius around each measured point was 
constant at any particular time point.  The strains at each point around the vessel were averaged 
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to give a mean incremental strain from frame to frame.  The analysis points were then 
compared with images from the ultrasound machine.  Regions that appeared dark and which 
had no speckle contrast were then manually dropped from the analysis.  An example of these 
regions is shown with a dashed red line in Figure 4-2.  After excluding such un-interpretable 
regions, average strain curves were plotted, and peaks and troughs were located and manually 
verified using a custom MatLab program.  The maximum circumferential strain value was 
calculated as the average difference between consecutive peaks to troughs throughout each cine 
loop.  Resulting means were then averaged in each experimental group at each aortic location 
and reported as mean ± SEM.  In addition to calculating strains, vessel cross-sectional areas 
were determined from scaled ultrasound images. These areas were then used to determine if 
vessel diameters changed throughout the study. 
4.2.5 Statistics 
Statistical analyses were executed using Sigmaplot 11 (Systat Software, San Jose, CA). 
Comparisons between two groups were completed using an unpaired two-tailed Student’s t-
test.  Comparisons between 3 or more experimental groups and between time points were made 
using one-way ANOVA with Tukey post-hoc analyses.  All data is reported as mean ± SEM. 
4.3 Results 
4.3.1 Effects of diet on aortic strain 
The normal chow and high fat mice gained weight as expected based on vendor supplied 
data (Jackson Laboratory, Bar Harbor, ME).  To confirm the ability to measure strain in the 
mouse aorta, pre-op baseline data for mice in the four study groups were analyzed.  Data from 
all normal chow diet mice with all high fat diet mice were compared first (Figure 4-3).  The 
results demonstrate a consistency of measurements in the same aortic location with animals 
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consuming the same diet.  Additionally, our strain values were similar (maximum strains ~19-
20%) to those reported by Goergen et al. using MRI imaging.35  It also shows no statistically 
significant differences between normal chow and high fat diet mice at each segment along the 
aorta preoperatively.  However, differences in mechanical strain along the aorta in the normal 
chow and high fat groups were noted.  The major trend seen here is that in both the normal 
chow and high fat groups, the ascending aorta shows statistically significant higher strain 
values than the other anatomical locations (P < .05).  Additionally, the lowest strain values were 
observed in the arch segment (P < .05). 
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Figure 4-3: Comparison of baseline preoperative strain magnitudes. Comparisons are made across 6 aortic 
locations between normal chow and high fat diet mice. Statistical statements are noted in the inset table. No 
statistically significant differences were found between mice of different diets in any aortic location, though 
differentials were noted among segments as depicted. All statistical statements indicate that P<.05; all groups contain 
15 or more animals. *Indicates statistical difference from high-fat ascending aorta; #indicates statistical difference 
from normal chow ascending aorta; and @indicates statistical difference from high-fat aortic arch. 
4.3.2 Short term impact of Angiotensin-II treatment on mechanical strain 
Using the short-term arm of the study, the acute effects of the Ang II treatment 
(1000ng/kg/min) on mechanical strain in normal chow and high fat mice (Figure 4-4, A) were 
isolated.  There is a consistent trend toward decreased strains in all aortic locations after just 3 
days of Ang II treatment in the normal chow group.  Reductions in the supraceliac, thoracic, 
and ascending aortic locations were statistically significant (P < .05).  None of these animals 
showed changes in aortic diameter at day 3 post-Ang II infusion. 
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Similar results were found in the short-term study for the mice fed on a high fat diet (Figure 
4-4, B).  In this group, there was a similar trend toward decreased strain at the day 3 time point, 
with statistically significant decreases occurring in the supraceliac segment.  Unlike the normal 
chow group, however, two animals in this group formed aortic aneurysms (at least 1.5 times 
greater diameter than initial measurement; paravisceral and supraceliac regions) by day 3 post-
op, while one animal died of aortic arch rupture prior to day 3. 
4.3.3 Long term effects of angiotensin II treatment on mechanical strain 
Long-term changes in strain were analyzed for both the normal chow and high fat groups 
receiving Ang II (500ng/kg/min).  In both groups there was a progressive trend towards 
decreased mechanical strains from pre-op to day 14 to 28 strains (Figure 4-4, C and D).  The 
largest reduction of strain was observed in the para-visceral, and the supra-celiac segments in 
high fat diet mice (Figure 4-4, D).  The majority of these reductions in strain corresponded 
directly with aneurysm formation. It should be noted that both the normal chow and high fat 
groups contained animals with and without aneurysm development by day 28. 
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Figure 4-4: Short and long term effects of Ang II on normal and high fat animals. (A) Short-term effects of Ang 
II treatment on animals fed on normal chow diets. (B) Short-term effects of Ang II treatment on animals consuming 
only high fat diets since week 10 of age. (C) Long-term effects of Ang II treatment on normal chow animals. (D) Long-
term effects of Ang II on high fat animals.  * Indicates P<.05. 
4.3.4 Relative effects of different factors on mechanical strain 
The design of this study enabled the isolation of the effects of Ang II treatment from those of 
aneurysm formation.  The percent change in strain from pre-op strain due to Ang II treatment 
alone, aneurysm formation at day 14, and aneurysm formation at day 28 for normal chow and 
high fat animals was determined (Figure 4-5).  These data suggest that both the Ang II 
treatment and the actual formation of aneurysm play a role in reducing strain in the aorta.  The 
results in Figure 4-5 also suggest that aneurysmal degeneration and physical remodeling of the 
wall may play a large role in decreasing circumferential strains.  Mural thrombus was a 
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common finding in the Ang II mice.  The thrombus likely contributed to the overall decrease in 
strain of the aneurismal aortic wall.  However, the current study does not have enough power 
to tease out the component contributions of mural thrombus vs other factors on the decreased 
strain found in aneurismal segments. 
Overall in this study, there were clear differences in aneurysm formation between the 
normal chow and high fat diet groups.  At day 3 in the short term arm of our study, 0% (n=8) of 
normal chow animals had formed aneurysms.  High fat animals at day 3, however, 
demonstrated an aneurysm formation rate of 50% (n=6).  One of these high fat animals died of 
aortic arch aneurysm and rupture prior to day 3.  In the long term arm, similar rates of 
aneurysm formation between normal chow and high fat animals was observed.  At week 4 there 
was an aneurysm rate of 70% (including animals which died of aneurysmal arch rupture by 
week 4).  In contrast an aneurysm formation rate of 88% was seen in high fat animals.  We were 
not, however, able to distinguish a difference in pre-Ang II strain measurements in animals that 
subsequently develop aneurysms vs no aneurysms (no predictive capability). 
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Figure 4-5: Effects of Ang II and aneurismal degeneration on aortic wall strain. Data are reported as percent 
change in strain from pre-operative strain.  The Ang II group contains only animals that did not have aneurysms at 
Day 3 from the early study. Day 14 and Day 28 aneurismal degeneration groups only contain data from animals that 
had aneurismal expansion (increase in size of 150% or more) detected via ultrasound scans. Data for normal chow 
and high fat groups are shown in (A) and (B), respectively. 
4.4 Discussion 
AAAs lead to over 15,000 deaths per year in the United States alone, and some even 
estimate the annual death rate from AAA to be as high as 30,000.  Most are asymptomatic until 
catastrophic rupture, and ruptured AAAs continue to have high morbidity and mortality.204  
Hence, there is an undeniable need to fully understand the pathophysiology of AAAs and to 
improve patient selection for expansion and rupture prediction and prevention. 
The exact pathogenesis of AAA is complex and still unknown, but clinical risk factors are 
known which include smoking, male gender, age, family history, previous vascular disease, 
 57 
Chapter 4: Objective 1B 
hypertension, and hypercholesterolemia.170  Biologically aortic wall inflammation and oxidative 
stress appear to hold a role in AAA formation.205  The immune system is also believed to be 
mechanistically involved in the development of AAAs, along with a reduction in the density of 
smooth muscle cells, elastin and collagen fibers, which are degraded by proteolytic enzymes 
(mostly matrix metalloproteinases).206  The aortic wall structurally depends on elastin and 
collagen, but in aneurysm disease medial elastin degradation (elastolysis) occurs, causing 
dilatation of the aorta.170 
Biomechanical forces stand as a pivotal factor in AAA development and rupture.190-192, 207  
Peak AAA wall stress may be superior to maximum diameter in differentiating rupture risk.190, 
192  Additionally, due to unevenly distributed wall stresses, overall AAA wall stress does not 
directly depend on maximum diameter.208 
Ultrasound serves as a useful tool not only clinically for infrarenal aortic aneurysm 
surveillance, but also experimentally for quantification of aortic morphology and biomechanics.  
Contemporary high-frequency ultrasound represents a significant improvement over prior 
techniques in evaluating the aorta in murine AAA models.  The approach is relatively non-
invasive imaging, can be performed longitudinally, allows for examination of aneurysm 
prone/protected regions, and in combination with analytical approaches such as speckle 
tracking for strain analyses it provides more information than previous murine AAA imaging 
studies that only measured maximum aortic diameter.  The primary downside is the expense of 
the device and technical expertise needed to acquire image data, though it has been shown that 
high-frequency ultrasound can be performed with relatively small intra-individual and inter-
individual variance.38  Other groups have used in vivo pulse wave velocity in non-aneurysm 
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studies to show that apoE-/- mice infused with Ang II have significantly increased vessel 
stiffness compared with controls after 30 days.209  However, this report did not provide 
localized stiffness data.  Other related imaging modalities are in development for in vivo murine 
studies—for example quantification of murine aortic cyclic strain and motion using 3D MR 
angiography in relation to its implications for AAA growth.35 
 In the current experiment high frequency ultrasound was used to assess aortic wall 
strain in apoE-/- mice at selected time points during Ang II-induced aortic aneurysm 
development.  Wall strain correlated with the pathological events that occurred in different 
segments of the aorta.  Baseline wall strain was measured in selected segments along the aorta, 
revealing a rather high strain in the ascending aorta, while the aortic arch manifested the lowest 
basic strain.  As Ang II was given to our mice, the ascending segment did not manifest 
aneurysmal dilatation.  However, as expected, the arch responded dramatically by developing 
aneurysms, some of which ruptured within the very early stage (3 days).  Cao et al. described 
the phenomenon of early development of aneurysm with subsequent rupture, ranging at 25% of 
all mice.196  In their series, 44% presented with arch aneurysms.  The prevalence of early 
development of aortic aneurysm correlates with age.  Also, it is assumed to represent a genetic 
predilection of some of the apoE-/- mice, presenting with aortic arch structural aberration, 
which yields a stiffer vessel wall.  The later phase of Ang II infusion (as assessed on days 14 
through 28) was characterized by a significant reduction of wall strain in the supra-renal 
segment, namely the para-visceral, and supra-celiac regions.  It is not surprising, therefore, that 
those segments are most affected by aneurysm formation in this model.  Notably, the 
aneurysmal dilatation by itself leads to an increased vessel diameter, which further decreases 
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wall strain locally.  The data collected via longitudinal non-invasive assessments emphasize the 
significance of anatomical localization of regional circumferential wall strain characteristics as a 
predictor for potential future events.  
Dietary manipulations of murine models have emerged as a useful experimental tool,210 and 
such manipulations are known to impact factors key to development of arterial aneurysms.211  
Obesity has been shown to increase peri-aortic adipose tissue inflammation leading to enhanced 
incidence of AAA in the Ang II murine model.  We sought to characterize the effect of these 
changes on the aortic wall elasticity and association with enhanced aneurysm formation.  Under 
the conditions of our experiments we found no differences between normal chow mice and high 
fat mice in any region along the aorta preoperatively.  This suggests that the hyperlipidemic 
state associated with short term high fat feeding alone does not significantly alter the structural 
components of the aortic wall, but rather enhances the inflammatory and remodeling response 
associated with Ang II treatment.  There was no significant difference between atherosclerotic 
plaque deposition on the aortic wall observed at autopsy between the normal chow and high fat 
animals.  However, longer term high fat feeding as well as more advanced age may lead to 
enhanced atherosclerotic changes that can result in loss of aortic elasticity and increased risk for 
aneurysmal degeneration, but this remains to be characterized in future investigations. 
Potential parallel applications for high frequency ultrasound are numerous.  Our methods 
could be used to quantify circumferential strain in other murine models of disease and after 
interventions (e.g. statins, anti-hypertensive therapies, anti-inflammatory agents, etc.).  
Furthermore, most AAAs are asymmetric.  It has been shown that asymmetry/shape has a 
substantial influence on the distribution of wall stress within the aneurysm,190 and our strategies 
 60 
Chapter 4: Objective 1B 
could be expanded to interrogate the effect of asymmetric circumferential strain on AAA 
formation and rupture.  Clinically there are significant shortfalls with current AAA 
management pathways, as the fundamental strategy of using size imaging as a stand-alone to 
diagnose and provide prognostic information regarding AAA does not provide complete data 
to identify which AAAs are most likely to continue to increase in size and be at risk for rupture.  
A more complete ability to predict AAA progression may allow improved AAA management.212 
A limitation of this study is that blood pressure was not closely measured in the mice.  
However, it has been reported previously that blood pressure does not affect Ang II related 
AAA development213, and it is likely that for the range of blood pressures for the experimental 
animals the impact on strain is minimal.  Systemic blood pressure is necessary for calculation of 
stiffness index and other relevant hemodynamic parameters.  We assumed that at day 3 no 
animals would develop gross aneurismal changes, and that any difference in strain measured 
would be from the effect of Ang II alone rather than contributions from structural changes from 
an enlarging aneurysm/thrombus.  The combination of high fat feeding and high Ang II dose 
led to unexpected aneurysm development at day 3.  It is possible that by reducing the dose of 
Ang II we could decrease the rate of early aneurysm formation and better determine the effects 
of the Ang II treatment alone.  Finally, due to the resolution limitations of current ultrasound 
technology, we were unable to accurately differentiate between the intra-luminal and extra-
luminal aortic wall.  For these reasons, we only calculated and reported the circumferential 
strains (not radial strain) on the intra-luminal wall, which was clearly visible in the ultrasound 
images. 
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In conclusion, the combination of high-frequency ultrasound imaging and speckle tracking 
allows the quantification of the changes in circumferential strain of the aorta during AAA 
development in apoE-/- mice infused with Ang II.  The combination of these techniques 
demonstrated that the aorta significantly stiffens (has decreased strain) shortly after the infusion 
of Ang II into apoE-/- mice and after aneurysm formation in these mice.  Measurements at later 
time points revealed progressive decrease in strain in the supra-renal aorta, which is the 
segment most likely to be involved in aneurysm formation.  The delineation of the 
biomechanical factors and natural history of AAA development in animal models of the disease 
in combination with our continuously improving armamentarium of biologic assays will 
provide insights into the factors associated with initiation and propagation of AAAs in humans.  
4.5 Conclusions 
The methodologies used to measure strains in this chapter represent a novel and useful 
approach to noninvasively determine wall strains in the murine model. In this chapter, we 
demonstrated that there are baseline differences in strain amongst aortic regions with the 
greatest arterial strain in the ascending aorta region. Additionally, we found that mechanical 
strains in several regions were reduced very soon after the induction of aneurysms in the apoE-
/- mouse model infused with Ang II. These reductions in strain demonstrate that our method 
can measure small enough strain changes to determine changes in a murine model with small 
sample sizes and that this method is sensitive enough to determine changes in aortic strains due 
to disease conditions. This method enables research that noninvasively examines changes in 
vascular strains in a variety of biological systems. In the following chapters of this dissertation, 
this method is applied to a novel model of vascular intimal hyperplasia.  
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5 Objective 2: Determination of the relationship between circumferential 
wall strain and intimal hyperplasia 
Portions of this section are taken from The Journal of Vascular Surgery, In Press, John T 
Favreau, Chengwei Liu, Peng Yu, Ming Tao, Christine Mauro, Glenn R. Gaudette, C. Keith 
Ozaki, “Acute reductions in mechanical wall strain precede the formation of intimal 
hyperplasia in a murine model of arterial occlusive disease”, Copyright 2013, with permission 
from Elsevier (See Appendix A). 
5.1 Introduction 
In the first aim of this dissertation, we validated a novel method for measuring mechanical 
strains on the murine arterial wall using high frequency ultrasound. Having demonstrated the 
accuracy and precision of our method compared to another measurement technique, and 
applied our method to an in vivo model, our next objective is to determine what relationship 
exists between cyclic circumferential wall strain and intimal hyperplasia (IH). 
In this chapter, we hypothesize that there is a direct positive relationship between reduced 
cyclic arterial wall strain and the formation of IH. To test this hypothesis, we combined a 
validated murine model of IH37 with our method for measuring arterial wall strains in vivo44 to 
unravel the relationship between wall strain and neointima formation. 
5.2 Materials and methods 
5.2.1 Study design 
All animal experimental protocols used in this study complied with the Guide for the Care 
and Use of Laboratory Animals 214 and were approved by our local Institutional Animal Care 
and Use Committee. Male C57BL/6J mice (n=10) were purchased from the Jackson Laboratory 
(Bar Harbor, ME) and maintained on a normal chow diet.    
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5.2.2 Mouse model 
At eight weeks of age, general anesthesia was induced with 2% isoflurane gas in an 
induction chamber and then maintained via a nose cone with 1.0-1.5% isoflurane gas. A focal 
stenosis was created in the left distal common carotid artery (LCCA) as described previously.37 
Briefly, the LCCA was exposed and visualized via a midline incision using a surgical 
microscope (OPMI-MD, Carl Zeiss, Germany). A focal stenosis was created approximately 1mm 
proximal to the common carotid bifurcation by tying a 9-0 nylon suture around both the artery 
and a blunt 35 gauge needle (external diameter of 0.14 mm, item No. NF 35 BL; World Precision 
Instruments, Inc., Sarasota, FL). After removal of the needle, the vessel diameter was reduced 
by ~78%. Our previous studies have shown this diameter reduction will produce a reduction in 
luminal flow of ~85%.37 After creation of the focal stenosis, the surgical incision was closed and 
mice were allowed to recover. 
5.2.3 Ultrasound data acquisition 
Ultrasound cine loops of both the LCCA and right common carotid artery (RCCA) were 
recorded preoperatively and on post-op day 27. For ultrasound acquisition, mice were 
anesthetized using 1-2% isoflurane and body temperature was maintained on a moveable 
platform heated to 37 °C. A chemical depilatory was used to remove hair from the neck and 
pre-warmed Aquasonic 100H ultrasound transmission gel (Parker Laboratories, Inc., Fairfield, 
NJ) was applied. Using a Visualsonics Vevo 2100 Ultrasound Imaging System with MS700 50 
MHz linear array transducer (Visualsonics Inc., Toronto, ON, Canada), cine loops of cross-
sections of both the RCCA and LCCA were recorded. For the LCCA, loops were recorded 1mm, 
2mm and 3mm proximal to the focal stenosis and at similar locations for the RCCA (Figure 5-1). 
Cine loops for all time points and locations were recorded at 432 frames/s with 500 consecutive 
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frames acquired. Efforts were made to maintain depth of anesthesia with a heart rate of at least 
475 beats/minute and a respiratory rate of 75-100 breaths/minute during all data collection.  
 
Figure 5-1: Objective 2 study design.  A focal stenosis (green arrow) was made in the left common carotid artery 
1mm proximal to the carotid bifurcation. Mechanical (via ultrasound) and histological parameters were assessed 
1mm, 2mm, and 3mm proximal to the focal stenosis on the left side, and in corresponding locations on the 
contralateral side (blue lines). 
5.2.4 Strain calculations 
Ultrasound cine loops were loaded into VevoVasc software (Version 3.6.2.0, Visualsonics 
Inc.) and vascular walls were traced using the automatic edge detection tool. Movement of the 
carotid artery wall was then tracked through at least 5 cardiac cycles and vessel area was 
recorded over time. From the resulting area change curves, ideal vessel diameters were 
computed (assuming a circular cross-section) and circumferential wall strain curves (using 
Green’s definition215) were calculated across the 5 cardiac cycles. Average magnitude of cyclic 
wall strain from diastole to systole was calculated for each animal, time point and location. 
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Additionally, mean diastolic and systolic cross-sectional areas were computed and reported for 
each time point. 
5.2.5 Tissue Harvest and Histology 
On post-op day 28, mice were again anesthetized using 1-2% isoflurane anesthesia. The 
chest cavity was opened and the left ventricle of the heart was punctured with a 25 gauge 
cannula and blood was drained through an incision in the inferior vena cava. Lactated ringer’s 
solution was perfused under physiological pressure (100 mmHg) for 2-3 minutes then replaced 
with 10% buffered formalin for 5 minutes. The LCCA and RCCA were collected and fixed in the 
same formalin solution overnight. 
Tissue specimens were then dehydrated, cleared through several changes of ethanol and 
xylene and embedded in paraffin. Tissue cross-sections (6-μm thick) were collected throughout 
the tissue. Using the carotid bifurcation as a reference for the RCCA and the focal stenosis as a 
reference for the LCCA, tissue cross-sections were collected 1mm, 2mm and 3mm proximal to 
the focal stenosis and at corresponding locations on the right (the same locations at which wall 
strain was assessed using ultrasound). At each location, Masson’s trichrome stain was 
employed to visualize arterial structures via a microscope with high resolution camera (Axio A1 
microscope with vision 4.7 software; Carl Zeiss). The lumen dimensions, internal elastic lamina 
(IEL) length and external elastic lamina (EEL) length were identified and traced.  Assuming a 
circular cross-section in vivo, the areas and radii of the lumen, IEL and EEL were determined. 
From these values, mean intimal thickness, wall thickness, and intima:media thickness ratio 
were calculated. 
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5.2.6 Statistics 
Data are presented as mean and standard error of the mean. All statistical analyses were 
completed in Sigmaplot version 11 (Systat Software Inc., San Jose, CA, USA). Statistical 
comparisons amongst spatial regions for strain, histological measurements and diameters were 
performed using a one way ANOVA followed by a Tukey post-hoc test. Differences between 
pre-op and post-op day 28 timepoints and between contralateral control and experimental 
artery were determined using a paired t-test (paired by animal).  Statistical powers are reported 
for all negative statistical results. P<0.05 was considered significant for all tests. 
5.3 Results 
All animals survived surgery to tissue harvest. Three of the 10 mice had occluded LCCAs on 
harvest and their morphology data were not included in any of the analyses. Histology was 
available on all of the remaining animals. Due to technical difficulties related to visualizing the 
relatively low flow artery and edema, some day 27 strain data was unusable and thus is 
missing. The baseline data for these animals was included in the strain analyses. Table 5-A 
summarizes the data available and used for the following analyses. 
Table 5-A:  Sample sizes used for strain and histological analyses 
Timepoint 
2mm Strain 
(# of Regions) 
3mm Strain 
(# of Regions) 
4mm Strain 
(# of Regions) 
Histology 
(# of animals) 
Day 0 10 10 10  
Day 27 8 8 8  
Day 28    7 
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5.3.1 Wall strain analysis 
Wall strains at baseline (pre-op) were consistent in all regions of both the left and right 
common carotid artery with no significant differences (Figure 5-2; p=0.56; Power: 0.22). At day 
27, strains were reduced compared to pre-op measurements (p<0.001). Strains on the 
contralateral artery remained unchanged compared to pre-op strains at day 27 (p=0.719; Power: 
0.05). No regional differences in strain were seen amongst either the stenosis or contralateral 
locations at any time point. 
 
Figure 5-2: Regional differences in strain. Wall strains were assessed on the left (stenosed) and right (unaltered) 
common carotid artery in the regions shown in Figure 5-1. No differences amongst spatial locations were found on 
either side at any time point. (n=8 in all groups) *indicates P<.05 compared to pre-op values (tested via paired t-test). 
5.3.2 Histological analysis of wall adaptations 
Histological analysis of tissues collected at day 28 was completed in all animals with a 
patent LCCA (n=7).  Intimal thickness and wall thickness were computed at 2, 3 and 4 mm 
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proximal to the carotid bifurcation (regions which correspond to those where ultrasound data 
was acquired). IH occurred near the focal stenosis of the LCCA, but none was observed in the 
contralateral RCCA (Figure 5-3A). No regional differences were found in any calculated 
parameter amongst the three spatial regions. Mean wall thickness of the LCCA tended to be 
higher than that of RCCA, with a significantly 56% thicker wall 3 mm proximal to the 
bifurcation (P =0.012) (Figure 5-3B). 
 
Figure 5-3: Morphological analysis of day-28 carotid arteries.  (A) The intimal thickness of LCCA was 
significantly higher than that of RCCA at the same location. (B) LCCA tends to have higher wall thickness than its 
counterpart RCCA. (C) Representative histology for each of the three regions on the LCCA and RCCA. † indicates P < 
.05 compared to RCCA value at the same cross-sectional location (tested via paired t-test; n=7 in all groups). 
5.3.3 Temporal progression of arterial cross-sectional areas 
Arterial cross-sectional areas at both diastole and systole were assessed pre-op, and at post-
op day 27. Since no differences among spatial positions of either the LCCA or RCCA were 
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noted, strain values for all regions were analyzed together. Diastolic cross-sections in all spatial 
regions (2, 3 and 4 mm proximal to the carotid bifurcation) on the focal stenosis side were 
decreased at post-op day 27 compared to pre-op area (p=0.003). On the contralateral (right) side, 
diastolic areas increased from pre-op to post-op day 27 (0.10 ± 0.01 mm2 vs. 0.14 ± 0.01 mm2; 
p<0.001)  
Systolic cross-sectional areas were the same for the LCCA and RCCA at pre-op (0.15 ± 0.01 
mm2 vs. 0.15 ± 0.01 mm2; p=0.50; Power: 0.05). Systolic cross-sectional areas in the LCCA were 
decreased compared to pre-op at post-op day 27 (0.08 ± 0.01 mm2; p<0.001). In the RCCA, 
systolic cross-section increased compared to pre-op at day 27 (0.20 ± 0.01 mm2; p=0.01) (Figure 
5-4). 
 
Figure 5-4: Changes in (A) diastolic and (B) systolic lumen area. *Indicates P<.05 compared to pre-op values 
(tested via paired t-test; n=8 in all groups) 
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5.3.4 Relationship between Day 27 strain and Histological outcome 
As the results above demonstrate, we have found that there are no regional differences in 
circumferential wall strain amongst the 2mm, 3mm and 4mm locations proximal to the focal 
stenosis on either the stenosis vessel or contralateral control vessel. Additionally, we found no 
regional differences in either wall thickness or intimal thickness histological outcome amongst 
any of the regions. Consequently, we analyzed the relationship between day 27 strain and 
histological outcome as an aggregate of all of the regions, ignoring distance from the focal 
stenosis. 
Qualitative analysis of a plot of circumferential wall strain vs. intimal thickness shows that 
all regions have reduced strain values at day 27. Further, regions with high amounts of intimal 
hyperplasia appear to have lower strains compared to those with no intimal hyperplasia which 
exhibit a wide range of strains. Finally, we once again observed no trends toward differences 
amongst the three regions. 
Given the qualitative results in Figure 5-5, the differences in intimal thickness outcome were 
analyzed between regions with low strain and those with high strain. By examining a histogram 
of day 27 strains (Figure 5-6A), it was observed that the majority of strain values are in the 
range of 0.01- 0.08 and appear to be normally distributed.  In Figure 5-6B, the neointima 
formation in the 4 regions that have high strains (>0.08) was compared. Although no statistical 
differences occur between the low and high strain groups in either the wall thickness (p=0.357) 
measure or intimal thickness (p=0.145) measure, there appears to be a trend toward increased 
intimal and wall thickness in the low strain group. Since only 4 regions fell into the high strain 
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group, lack of statistical significance here could be due to a type 2 statistical error given that 
statistical power for both tests was only 0.05. 
 
Figure 5-5: Relationship between day 27 strain and day 28 intimal thickness. Although there is a wide range of 
regions with low intimal thickness, regions with significant neointima formation are confined to the low strain range.  
 
Figure 5-6: Quantitative relationship between day 27 strain and neointima formation. (A)  Histogram analysis 
of wall strains in all regions at day 27. (B) Analysis of wall thickness and intimal thickness between regions of low 
strain (<0.1) and those of high strain (>0.1). 
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5.4 Discussion 
In Objective 1 (Chapters 3 and 4), we demonstrated that our novel methods are capable of 
measuring circumferential wall strains in the murine vasculature. In the present chapter we 
demonstrate that there is a relationship between regional circumferential wall strain and the 
formation of intimal hyperplasia. In a previous study in our collaborator’s lab, we found that 
using the murine focal stenosis model results in a ~85% reduction in wall shear stress and a 
subsequent formation of IH in the vessel 1 month later.37  This finding is consistent with the 
large body of literature demonstrating a correlation between low wall shear stress and IH.82, 104, 
134, 162, 216-224 Additionally, in this previous study, we showed that immediately after creation of 
the focal stenosis, there may be a trend toward strain reduction (as measured by an optical 
method) in the region proximal to the stenosis.37  In this objective, we go on to demonstrate that 
a reduction in strain exists in nearly all regions at Day 27 post focal stenosis creation. 
Oscillatory wall strain is a measure of how much the vessel wall dilates from diastolic to 
systolic pressure in the average cardiac cycle. Given that the stress in the vessel wall is related to 
strain through the mechanical properties of the wall, reductions in mechanical strain observed 
herein are likely due to either changes in wall stiffness or changes in wall stress. Increases in 
vascular wall stiffness would result in the vessel wall stretching less between the diastolic and 
systolic blood pressures—thereby reducing oscillatory wall strain. Alternatively, the blood 
pressure itself or the wall thickness could change and affect the wall stress, resulting in changes 
in wall strain. Increases in wall thickness or decreases in pulse pressure could both result in 
reductions in wall strain. Interestingly, changes in mechanical strain are not observed in the 
contralateral control artery. This finding is confounded by the data in Figure 5-4 that shows an 
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increase in both contralateral diastolic and systolic areas. This suggests that although the vessel 
area is increasing, both diastolic and systolic area are increasing proportionally to maintain a 
constant cyclic wall strain.  On the stenosis (left) side, a decrease in both systolic and diastolic 
area was observed in addition to the reduction in strain, although the decrease appears to be 
greater in systolic area compared to diastolic area. 
A major limitation of the studies in this chapter is that the blood pressure and arterial wall 
thickness were not assessed. Ideally, blood pressures and wall thicknesses would be measured 
along with strain on both the experimental and contralateral arteries. Due to the small size of 
the murine blood vessels, the outer wall of the carotid artery cannot be differentiated from the 
surrounding tissues via contemporary ultrasound. Additionally, measurement of blood 
pressures within the vessel is limited by the arterial size. Given that the mouse carotid artery is 
typically about 300-400μm in lumen diameter37, 225 Insertion of even the smallest commercially 
available pressure catheters (300 microns in diameter, Fiso LS 0.9 French, Harvard Apparatus, 
Holliston, MA)  into the carotid artery would significantly impede blood flow and likely alter 
the entire in vivo model. 
Despite the limitations of this study, the results show a promising trend toward a 
relationship between mechanical strain and intimal hyperplasia in our murine model. The data 
in Figure 5-6 indicate a division of regions showing low or high strain and a trend toward low 
strain regions having more intimal hyperplasia. Given that nearly 2/3 of the regions analyzed 
demonstrated IH at day 28, it is possible that a more clear relationship could be found at earlier 
time points when less IH formation had occurred. In Specific Aim 3 (Chapters 6 and 7), we will 
further assess the temporal relationship between IH and cyclic wall strain.   
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6 Objective 3A: Determine the temporal progression of wall strain in the 
focal stenosis model 
Portions of this section are taken from The Journal of Vascular Surgery, In Press, John T 
Favreau, Chengwei Liu, Peng Yu, Ming Tao, Christine Mauro, Glenn R. Gaudette, C. Keith 
Ozaki, “Acute reductions in mechanical wall strain precede the formation of intimal 
hyperplasia in a murine model of arterial occlusive disease”, Copyright 2013, with permission 
from Elsevier (See Appendix A). 
6.1 Introduction 
In chapter 5 of this dissertation, we demonstrate that there is a relationship between 
reductions in mechanical strain and the formation of IH in a murine model. Although 
significant differences as a function of distance proximal to the focal stenosis were not observed 
in either strain or IH measurements, our data suggest that there may be a relationship between 
mechanical strain and IH in this model. To further understand this relationship, in this chapter 
we will aim to further delineate the progression of wall strain in this model. To accomplish this, 
wall strain was assessed at time points earlier than 28 days to determine when strain reductions 
occur in relation to IH at 28 days post-op. By examining more time points, we show how early 
detectable changes in strain occur in this model and gain a better understanding of when strains 
are reduced. 
6.2 Materials and methods 
6.2.1 Experimental Design 
We will re-use histological data collected for the animals in Objective 2 and assess 
ultrasound data collected in the same animals at the day 4 timepoint. Arterial wall strains were 
assessed in the same locations described in Chapter 5 using our ultrasound-based methodology 
at day 4 after the surgical procedure.  Day 4 strain outcomes were compared to day 28 
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histological outcomes presented in Objective 2.  The experimental design for this aim is shown 
in Figure 6-1. 
 
  
Figure 6-1: Schematic of Aim 3A study. A focal stenosis will be created using the methodology described in 
Chapter 5. Early strains, at day 4, will be compared to histological outcome at day 28.  
 
6.2.2 Relationship between early strain and eventual intimal hyperplasia 
Animals from Objective 2 are re-used for this chapter to determine the temporal progression 
of wall strains in this model. Ultrasound cine loops from day 4 post-op were collected and 
strain analyses were performed as described in Section 5.2.4. Cyclic wall strain, diastolic lumen 
area and systolic lumen area were assessed for the day 4 time point.  
6.2.1 Statistics 
Data are presented as mean and standard error of the mean. All statistical analyses were 
completed in Sigmaplot version 11 (Systat Software Inc., San Jose, CA, USA). Statistical 
comparisons amongst spatial regions for strain, histological measurements and diameters were 
performed using a one way ANOVA followed by a Tukey post-hoc test. Differences between 
pre-op, post-op day 4 and post-op day 28 time points were performed using a repeated 
measures ANOVA. Differences between contralateral control and experimental artery were 
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determined using a paired t-test (paired by animal). Statistical powers are reported for all 
negative statistical results. P<0.05 was considered significant for all tests. 
 
6.3 Results 
All animals survived surgery to tissue harvest. Three of the 10 mice had occluded LCCAs on 
harvest and their morphology data were not included in any of the analyses. Histology was 
available on all of the remaining animals. Due to technical difficulties related to visualizing the 
relatively low flow artery and edema, some day 4 strain data was unusable and thus is missing. 
The baseline data for these animals was included in the strain analyses. Table 6-A summarizes 
the data available and used for the following analyses. 
Table 6-A: Sample sizes used for strain and histological analyses on the LCCA.  *The lumen of some vessels 
were not visible via ultrasound and were therefore excluded. † 3 arteries were fully occluded at day 28 and therefore 
were not used for histological analysis 
Timepoint 
2mm Strain 
(# of Regions) 
3mm Strain 
(# of Regions) 
4mm Strain 
(# of Regions) 
Histology 
(# of animals) 
Day 0 10 10 10  
Day 4 9* 8* 9*  
Day 27 8* 8* 8*  
Day 28    7† 
 
6.3.1 Wall strain analysis 
Wall strains at baseline (pre-op) were consistent in all regions of both the left and right 
common carotid artery with no significant differences (Figure 5-2; p=0.56; Power: 0.05). At day 
4, all regions on the focal stenosis (left) side were significantly reduced compared to pre-op 
strains (p<0.001) while no changes in strain occurred on the contralateral (right) side (p=0.90; 
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Power: 0.05). At day 27, strains remained reduced compared to pre-op measurements but did 
not significantly reduce further compared to strains at day 4 (p=0.2). Strains on the contralateral 
artery remained unchanged compared to pre-op strains at day 27. No regional differences in 
strain were seen amongst either the stenosis or contralateral locations at any time point. 
6.3.2 Temporal progression of arterial cross-sectional areas 
Arterial cross-sectional areas at both diastole and systole were assessed pre-op, and at post-
op day 4 and day 27. Since no differences among spatial positions of either the LCCA or RCCA 
were noted, strain values for all regions were analyzed together. Diastolic cross-sections in all 
spatial regions (2, 3 and 4 mm proximal to the carotid bifurcation) on the focal stenosis side 
remained unchanged from pre-op to post-op day 4 (0.10 ± 0.01 mm2 vs. 0.12 ± 0.01 mm2; p=0.19; 
Power: 0.96). However, diastolic cross-sectional areas were decreased at post-op day 27 
compared to both pre-op area and post-op day 4 area (0.07 ± 0.01 mm2; p<0.001). On the 
contralateral (right) side, diastolic areas increased from pre-op to post-op day 4 (0.10 ± 0.01 mm2 
vs. 0.13 ± 0.01 mm2; p=0.009) and remained increased at post-op day 27 compared to pre-op 
(0.14 ± 0.01 mm2; p<0.001). Diastolic cross-sectional areas were statistically the same for the focal 
stenosis and contralateral arteries at pre-op and day 4, but contralateral cross-section was larger 
at post-op day 27 (p<0.001).  
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Figure 6-2: Regional differences in strain. Wall strains were assessed on the left (partially stenosed) and right 
(unaltered) common carotid artery in the regions shown in Figure 5-1. Average for each side indicates the average of 
all regions. No differences amongst spatial locations were found on either side at any time point. * indicates P<.05 
compared to pre-op values (n=8 in all groups). 
Systolic cross-sectional areas were the same for the LCCA and RCCA at pre-op (0.15 ± 0.01 
mm2 vs. 0.15 ± 0.01 mm2; p=0.50; Power: 0.05). Systolic cross-sectional areas in the LCCA were 
unchanged compared to pre-op at post-op day 4 (0.14 ± 0.01 mm2; p=0.64; Power: 0.9) but were 
decreased at post-op day 27 (0.08 ± 0.01 mm2; p<0.001). In the RCCA, systolic cross-section 
increased compared to pre-op at day 4 (0.17 ± 0.01 mm2; p=0.004) and continued to increase at 
post-op day 27 (0.20 ± 0.01 mm2; p=0.01) (Figure 5-4). 
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Figure 6-3: Changes in (A) diastolic and (B) systolic lumen area. *Indicates P<.05 compared to pre-op values; 
n=8 in all groups 
 
6.3.3 Relationship between acute strain and subsequent intimal thickness 
Analysis of the wall strain values in all regions at post-op day 4 using a histogram 
demonstrated a range of results (Figure 6-4A). To further analyze the acute changes in wall 
strain produced by this model, the LCCA data were divided into regions with strain >0.10 
(n=13) and those with strain ≤0.10 (n=13). The median was utilized as the threshold for the two 
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groups (the same cut off used in Aim 2). Of those regions with strains ≤0.10 at post-op day 4, all 
regions went on to form IH or to completely occlude by day 28. Regions with strain >0.1 at post-
op day 4, only 31% (4 regions) went on to form any detectable IH by day 28. 
Diastolic cross-sections remained unchanged in the strain >0.1 group from pre-op to day 4 
(0.10 ± 0.01 mm2 vs. 0.09 ± 0.01; P=.93; Power: 0.51) but were significantly reduced compared to 
pre-op at post-op day 27 (0.06 ± 0.01 mm2; P=.04). Diastolic areas in the strain ≤0.1 group were 
increased from pre-op to post-op day 4 (0.10 ± 0.01 mm2 vs. 0.15 ± 0.02 mm2) but returned to 
their pre-op levels at day 27 (0.09 ± 0.01 mm2; P=.40 compared to pre-op; Power: 0.86; Figure 
6-4B). Systolic areas, however, remained unchanged from pre-op to day 4 in both >0.1 (0.15 ± 
0.01 mm2 vs. 0.12 ± 0.02 mm2; P=.13; Power: 0.99) and ≤0.1 (0.16 ± 0.01 mm2 vs. 0.17 ± 0.02 mm2; 
P=.89; Power: 0.94) groups and both decreased below pre-op baseline by day 27 (P=.005 and 
P=.01, respectively; Figure 6-4C). The strain >0.1 group had significantly smaller intimal 
thickness than the strain ≤0.1 group (8 ± 4 μm vs. 32 ± 7 μm; P=.006). Similarly, the strain >0.1 
group had both a smaller wall thickness (82 ± 7 µm vs. 111 ± 6 µm; P=.009) and intima:media 
area ratio (0.19 ± 0.10 vs. 0.81 ± 0.19; P=0.006; Figure 6-4D).  
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Figure 6-4: Differences in LCCA regions with low (<0.1) and high (>0.1) day 4 strain.  (A) Histogram analysis 
showing the distribution of strain values amongst regions with cut off value. (B) Histological outcome of LCCA 
regions with low and high strain. ‡ indicates P<.05 vs. low strain values. (C) Changes in LCCA area at diastole over 
time in low and high strain groups. (D) Changes in LCCA area at systole over time in low and high strain groups. (E) 
Linear fit between wall strain at day 4 and intimal thickness at day 28 * indicates P<.05 compared to pre-op values. 
 
6.4 Discussion 
Given the results of Chapter 5, we believe that the temporal progression of strains may be 
important in regards to IH formation. Since we suspect that IH does not form before day 4, it is 
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important to determine exactly how early strain reductions occur and how early IH forms in 
this model. By experimentally demonstrating that strains reduce before IH forms, these 
experiments could effectively support our overall hypothesis: that reductions in oscillatory wall 
strain precede the formation of IH in a murine model of intimal hyperplasia.  
Herein, we find that vessels with early (four days after focal stenosis) low wall strain 
consistently develop IH 28 days after creation of an outflow focal stenosis. Furthermore, only 
31% of arteries that demonstrated high strain early went on to develop a measurable amount of 
IH. Such an analytical approach stands as a reasonable strategy to understand this small 
dataset. However, via multiple linear regression (intimal thickness as a dependent variable, wall 
strain and location proximal to the focal stenosis as independent variables), IH can be modeled 
as a linear combination of wall strain and distance proximal to the stenosis. Wall strain appears 
to account for the ability to predict IH (P=0.007) while location does not (P=0.343). Again, 
application of multiple linear regression to these data is limited by the small sample size and 
goodness of fit was suboptimal (R2= 0.36). 
Wall strains measured herein were oscillatory, meaning that stretch from diastole to systole 
was measured. In order to better understand how wall strains are reduced in the short-term, 
diastolic and systolic areas were assessed. In the low strain group, a short-term reduction in 
diastolic lumen area was shown while no changes in systolic area were found. In the high strain 
group, no changes in diastolic or systolic area were observed. Our results demonstrate a 
decrease in LCCA vessel diameter in all mice by day 27 post-op, a finding that was previously 
reported at 2 weeks post-operatively in a similar flow model in rabbits.226 However, we reveal at 
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4 days that diastolic diameter increases significantly in animals that will eventually form IH, a 
phenomenon that has not been previously reported. 
We speculate that the lower level of strain early is likely associated with altered vessel wall 
properties (biologic and mechanical). Though they have high heart rates, mice are known to 
have blood pressures similar to humans. Assuming a systolic pressure of 120 mmHg and a 
diastolic pressure of 80 mmHg, the 28 day wall modulus of elasticity (using a thin wall model 
based on the Law of Laplace and assuming linear vessel properties) yielded 152 ± 27 kPa for the 
low strain group and 100 ± 17 kPa in the high strain cohort. These computed elasticities fall in 
the same order of magnitude as those computed using more accurate (pressure based) 
measurements in previous studies.227 Although there was a trend toward higher modulus of 
elasticity in the low strain group, there is no statistical difference between the two groups 
(P=.10). These changes in strain could be directly related to changes in ECM or elastin content in 
the vessel wall. In particular, similar mechanical responses have been observed in vitro due to 
application of elastase to the vessel wall.228 Additionally, others have reported that expression of 
GAGs such as hyaluronic acid can be changed during an intimal hyperplastic response.229 
The early reductions in mechanical strain demonstrated in this chapter have important 
implications to the relation between mechanical strain and IH in this model. Given that we do 
not expect significant IH to occur by the day 4 timepoint, it is possible that the early reductions 
in strain could be a result of important biological changes in the wall that occur as a result of the 
focal stenosis. In order to better understand the underlying cause of this reduction in strain, 
Chapter 7 will examine the temporal changes in IH and the acute (immediately post-op) 
changes in mechanical strain. 
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7 Objective 3B: Determine the temporal progression of intimal 
hyperplasia in the focal stenosis model  
7.1 Introduction 
The results presented in Chapter 5 (Objective 2) and Chapter 6 (Objective 3A) of this 
dissertation demonstrate compelling evidence for a temporal relationship between changes in 
wall strain and intimal hyperplasia in our murine model. In Chapter 6, we demonstrated that 
100% of regions with low mechanical strain (<0.1) at day 4 went on to form IH by post-op day 
28. In contrast, only 31% of regions with high mechanical strain (>0.1) went on to form IH. These 
findings suggest a promising link between changes in mechanical strain and IH. 
From a mechanical standpoint, the reductions in mechanical strains seen at post-op day 27 
(Chapter 5) were most likely due to the increased wall thickness, changes in diastolic diameter 
and/or changes in wall mechanical properties. Reduced strains observed at post-op day 4, 
however suggest a more mechanistic role of strain reduction in the formation of IH. Although it 
was not confirmed in the previous studies, we believed that it is highly unlikely that significant 
changes in wall thickness due to IH have occurred by post-op day 4, thus eliminating increased 
wall thickness as a key regulator of strain. An idea that is supported by previous literature in 
other murine models of IH. 230-232 In this chapter, we will assess IH formation via histology at 
day 4 to determine if the wall thickness has significantly changed by day 4 post-op. 
A second possible cause of reduced strains at day 4 would be that placement of the suture 
immediately and directly causes reductions in mechanical strain. To assess this possibility, we 
measure strains immediately after focal stenosis creation and determine if reductions occur 
immediately upon focal stenosis creation. In this chapter, we aim to further understand the 
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relationship between oscillatory strain reduction and IH in order to present a clearer picture of 
the temporal progression of both mechanical strain and IH in this model.  
7.2 Materials and methods 
7.2.1 Experimental design 
The validated focal stenosis model used in the previous aims was once again used in this 
objective. Thirty wild-type mice (C57BL/6J, The Jackson Laboratory) were randomly split into 
sham control (10 mice) and experimental (20 mice) groups. The experimental timeline for all 
Aim 3B studies is shown in Figure 7-1. 
  
Figure 7-1: Experimental design for Aim 3B studies. Aim 3B animals were assessed via ultrasound at pre-op, 
immediately post-op and at post-op day 4. Animals were euthanized for histological analysis at day 4 to determine if 
significant IH is present at post-op day 4. 
7.2.2 Ultrasound data acquisition 
All sham and experimental animals were anesthetized and scanned using ultrasound 2-3 
days prior to operation, immediately post-op and at post-op day 4 as described in section 5.2.3. 
Ultrasound cine loops were recorded at 2mm, 3mm and 4mm proximal to the carotid 
bifurcation on both the RCCA and LCCA. Data recorded in this Aim were collected using an 
MS700 ultrasound transducer and Visualsonics Vevo2100 system.  
Each carotid was first visualized in longitudinal section to reveal the location of the 
bifurcation. At all time points, color Doppler cine loops were recorded in longitudinal section to 
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verify blood flow distal to the focal stenosis. After centering the probe on the carotid 
bifurcation, the probe was rotated 90 degrees to reveal a cross-sectional view of the artery. A 
stage micrometer was then used to move the probe 2mm, 3mm and 4mm with respect to the 
animal. At each location, 1000 frame cine loops were recorded at 534 frames per second for 
strain analysis. Ultrasound cross-sectional cine loops were analyzed using VevoVasc software 
using the same methodology described in Section 5.2.4.  
7.2.3 Focal stenosis model 
For experimental animals the same focal stenosis model employed in Chapter 5 was used 
(see section 5.2.2). For sham animals, the LCCA was surgically exposed following the same 
procedure used for experimental animals. After LCCA exposure, sham animal surgical sites 
were closed without manipulating the LCCA. All sham and experimental animals were scanned 
using ultrasound immediately post-op. 
At post-op day 4, experimental, and sham animals were anesthetized and scanned via 
ultrasound for a final time. Animals were then transported to the O.R. and perfusion fixed as 
described in section 5.2.5.  
7.2.4 Quantification of Intimal Thickness and Wall Thickness 
In order to quantify wall morphology, a custom, semi-automated MatLab (Mathworks) 
script was developed to measure the cross-sectional area and average wall thicknesses of 
individual vascular layers. Sections of each vessel at 2, 3 and 4 mm proximal to the carotid 
bifurcation were stained using Masson’s Trichrome (see Appendix B for protocol). Trichrome 
sections were imaged on a Leica DMLB2 upright microscope fitted with a DFC 480 c-mount 
microscope camera (Leica Microsystems, Buffalo Grove, IL).  The resulting images were loaded 
into MatLab. To determine lumen area, the images were converted to grayscale and 
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automatically thresholded to yield a black and white image. The lumen was selected and the 
pixel area was automatically quantified. Internal elastic lamina, external elastic lamina and 
outer vessel perimeters were then manually traced in MatLab. Cross-sectional areas of each 
region (in pixels) were then converted to physical areas (based on a scaled image taken on the 
same scope camera and objective). Wall thickness and intimal thickness were computed as 
described in section 5.2.5. Thickness values were averaged from 3 sections in each artery. 
Appendix D provides further details on the methods used to determine intimal and wall 
thicknesses. 
7.2.5 Assessment of cell type markers 
In order to determine which cell types are present in the arterial wall at day 4, a triple 
immunohistochemical stain was developed to assess 3 different cell types related to the vascular 
wall and IH. Myosin heavy chain, a marker of contractile smooth muscle cells,233 was stained 
along with CD31 (PECAM-1),234 a marker of vascular endothelial cells. Finally, the presence of 
leukocytes was assessed using CD45, an antigen common to all leukocytes.235 Briefly, tissue 
sections were rehydrated through several changes of xylenes and ethanols. Heat induced 
epitope retrieval was completed using a pH 6.0 Citrate buffer and pressure cooker. Sections 
were permeabilized with triton-x, blocked with normal goat serum and simultaneously treated 
with mouse anti-myosin heavy chain, rabbit anti cd-31 and rat anti-mouse cd45 overnight at 
4°C. Sections were then simultaneously treated with Alexa-fluor 488 goat anti-rat, Alexa-fluor 
568 goat anti-rabbit and Alexa-fluor 633 goat anti-mouse. Sections were then counter stained 
with Hoechst 33342 dye and coverslipped (for details of the staining process used here, see 
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Appendix B). Healthy mouse heart sections and intestine sections were run simultaneously as 
positive and primary delete controls. 
Stained sections were imaged on a laser confocal microscope (Leica TCS SP5, Leica 
Microsystems, Buffalo Grove, IL) with 4 photomultiplier tubes set to sequential mode. 
Maximum projection images of sections were imaged at 40x and 63x oil where appropriate. 
7.2.6 Assessment of cell proliferation 
To assess cellular proliferation, sections were immunostained simultaneously for alpha 
smooth muscle actin and ki-67, markers of smooth muscle cells and proliferating cells 
respectively. Briefly, tissue sections were rehydrated through several changes of xylenes and 
ethanols. Heat induced epitope retrieval was completed using a pH 9.0 tris-EDTA buffer and 
pressure cooker. Sections were permeabilized with triton-x, blocked with normal goat serum 
and simultaneously treated with mouse anti alpha smooth muscle actin and rabbit anti ki-67 
overnight at 4°C. Sections were then simultaneously treated with Alexa-fluor 488 goat anti-
mouse and Alexa-fluor 568 goat anti-rabbit. Sections were then counter stained with Hoechst 
33342 dye and coverslipped (for details of the staining process used here, see Appendix B). 
Mouse intestine controls were run simultaneously as positive and primary delete controls. 
Sections were imaged with confocal microscopy as described in section 7.2.5. 
7.2.7 Assessment of glycosaminoglycan synthesis 
To assess GAG synthesis, the protocol described by Shukla and colleagues236 was used. 
Briefly, tissue sections were rehydrated through several changes of xylenes and ethanols and 
permeabilized with triton-x. Negative controls were digested with hyaluronidase in a sodium 
acetate buffer at 37°C for 1 hr. Tissue sections were then blocked with goat serum and bovine 
serum albumin and incubated simultaneously with hyaluronic acid binding protein and rabbit 
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anti-mouse versican overnight at 4°C. Sections were then treated with Alexafluor 488 goat anti-
rabbit and Alexafluor 568 Streptavidin for 1 hr at room temperature. Sections were 
counterstained with Hoechst dye and coverslipped. Sections were imaged with confocal 
microscopy as described in section 7.2.5. 
7.2.8 Statistical Analyses 
Data are presented as mean and standard error of the mean. All statistical analyses were 
completed in Sigmaplot version 11 (Systat Software Inc., San Jose, CA, USA). Statistical 
comparisons amongst spatial regions for strain, histological measurements and diameters were 
performed using a one way ANOVA followed by a Tukey post-hoc test. Differences between 
pre-op, post-op day 4 and post-op day 28 time points were performed using a repeated 
measures ANOVA. Differences between contralateral control and experimental artery were 
determined using a paired t-test (paired by animal). Statistical powers are reported for all 
negative statistical results. P<0.05 was considered significant for all tests. 
7.3 Results 
All animals survived to tissue harvest and ultrasound data acquisition for all regions and all 
time points was successful. Additionally, blood flow was evident distal to all focal stenoses at 
day 4 as assessed using color Doppler ultrasound. Strain data for all animals and regions was 
available and is reported below. Histology for half of the animals discussed in the methods 
section was sent to another lab for additional analysis. Thus, histology for 10 experimental 
animals and 5 sham animals is reported below. 
7.3.1 Ultrasound strain analysis 
Mean oscillatory wall strains in sham controls (sham LCCA), contralateral controls 
(experimental RCCA) and experimental LCCAs were consistent at pre-op (0.27 ± 0.01 vs 0.29 ± 
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0.01 vs 0.28 ± 0.01, p=0.50; Power: 0.05). Shortly after focal stenosis placement (post-op day 0), 
LCCA strains did not change compared to pre-op in either the sham or experimental group 
(sham: 0.24 ± 0.02, p=0.24 (Power: 0.12) vs. pre-op; experimental: 0.26 ± 0.01, p=0.43 (Power: 
1.0)). At post-op day 4, experimental LCCA strains were significantly reduced (0.18 ± 0.01) 
compared to pre-op values (p<.0001), sham controls (0.26 ± 0.01; p<.001) and contralateral 
controls (0.24 ± 0.01; p<.001). Strain data averaged by animal are shown in Figure 7-2. 
Data were also analyzed by spatial region (2mm, 3mm and 4mm proximal to the 
bifurcation). No differences were found amongst the three spatial regions at any timepoint in 
either the sham control LCCA or the experimental LCCA. Experimental LCCA strains were 
reduced in all 3 regions at day 4 compared to pre-op, post-op day 0 and sham post-op day 4 
data. Figure 7-3 shows the regional changes in mechanical strain. 
 
Figure 7-2: Average oscillatory wall strain.  Average wall strain at Pre-op, Post-op Day 0 and Post-op day 4. 
Averages are for Sham control (n=10), Contralateral RCCA control (n=20) and Experimental LCCA (n=20) * indicates 
p<0.001; n=10 in sham group and n=20 in contralateral control and experimental group. 
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Figure 7-3: Average regional oscillatory wall strains. Regional wall strains were consistent amongst the three 
regions assessed at all time points. * indicates p<0.05 vs. sham control. † indicates p<0.05 vs. Pre-op. ‡ indicates p<0.05 
vs. post-op day 0. ; n=10 in sham group and n=20 in experimental group. 
As in the data presented in Aim 3A, strains were significantly reduced in many animals at 
day 4. Figure 7-4 shows the changes in strain levels over time in the experimental animals vs. 
both controls. Individual data points (for each animal) are plotted to demonstrate progression of 
strain levels. 
 
Figure 7-4: Progression of strain in control and experimental arteries. Strains in both control groups remain 
approximately constant throughout the study. Strains in experimental arteries, however, are reduced at day 4 post-
op. 
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 Figure 7-5: Histogram analysis of strain data at each time point. Strain levels were fairly consistent in all 
time points and groups except for the strain levels in the experimental animals at day 4 post-op. Dotted line through 
post-op day 4 data indicates the minimum control strain cut off used to analyze strain in the document. 
7.3.2 Changes in wall cross-sectional area 
Wall cross-sectional areas were measured at diastole and systole using ultrasound. Diastolic 
areas were the same in sham, contralateral and experimental arteries at pre-op (0.13 ± .02 mm2 
vs. 0.14 ± 0.02 mm2 vs. 0.15 ±0.02 mm2; p=0.36; Power: 0.06). Similarly, systolic areas were the 
same in sham, contralateral and experimental arteries at pre-op (0.20 ± .03 mm2 vs. 0.22 ± 0.03 
mm2 vs. 0.22 ±0.03 mm2; p=0.17; Power: 0.18). Sham control arteries remained unchanged from 
pre-op at both post-op day 0 and day 4. At post-op day 0, contralateral control diastolic and 
systolic areas were both significantly increased compared to pre-op (0.18 ± 0.04 mm2, p=0.002 
and 0.26 ± 0.04 mm2, p<0.001 respectively). Conversely, experimental diastolic and systolic areas 
were significantly decreased at post-op day 4 compared to pre-op (0.12 ± 0.02 mm2, p=0.17 and 
0.17 ± 0.03 mm2 p<0.001 respectively). At post-op day 4, contralateral control diastolic and 
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systolic areas returned to their pre-op levels (0.15 ± 0.04 mm2, p=0.80 vs. pre-op; Power: 0.91 and 
0.22 ± 0.06 mm2, p=0.99 vs pre-op, Power: 0.80; respectively). Experimental artery diastolic areas 
increased back to pre-op levels at day 4 but still had significantly reduced systolic areas (0.13 ± 
0.04 mm2, p=0.32 vs. pre-op, Power: 0.58; and 0.17 ± 0.05 mm2, p<0.001 vs pre-op; respectively). 
Figure 7-6 shows the changes in diastolic and systolic area over time throughout the Aim 3B 
experiments. 
 
Figure 7-6: Changes in arterial cross-sectional area throughout the experiment A) Changes in diastolic cross-
sectional area over time. B) Changes in systolic area over time. * indicates p<0.05; n=10 in sham group and n=20 in 
contralateral control and experimental group. 
 94 
Chapter 7: Objective 3B 
7.3.3 Histological analysis of intimal thickness 
Masson’s trichrome stain on day 4 tissues was used to assess the mean intimal thickness, 
and wall thickness for all vessels. Figure 7-7 shows representative images of vessels from each 
group with the manual tracing overlaid.  
Intimal thickness at day 4 was consistent amongst the three groups with no statistical 
differences amongst the groups. Intimal thickness for sham, contralateral and experimental 
arteries were 2.5 ± 0.3 μm, 2.1 ± 0.3 μm and 2.6 ± 0.1 μm respectively (p=0.12; Power: 0.25). 
Intimal thicknesses are plotted in Figure 7-8A. Additionally, no significant differences in total 
wall thickness were observed between control and experimental arteries. Sham, contralateral 
and experimental arteries had total wall thicknesses of 53.9 ± 3.5 μm, 64.6 ± 4.8 μm and 58.3 ± 3.4 
μm respectively (p=0.69; Power: 0.05; Figure 7-8B). 
 
Figure 7-7: Use of Masson's Trichrome to find thickness of vessel layers. Representative sections are shown 
with overlaid green tracings of the two lamina and the outer extent of the vessel. Wall thickness values were 
computed using these tracings. A) Sham control, B) Contralateral control, C) Experimental LCCA. Scale bar: 100μm 
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Figure 7-8: Intimal thickness and wall thickness at day 4. A) Intimal thickness at day 4. B) Wall thickness at day 
4; n=5 in sham group and n=10 in contralateral control and experimental group. 
7.3.4 Relationship between strain and diameter 
Strain magnitudes were divided into high and low strains in two different ways. In Figure 
7-9 A-C (left), strain was cut off based on the lowest observed control strain value (0.16, see 
dotted lines in Figure 7-5). A trend toward increased diastolic and systolic areas (Figure 7-9B, C) 
was observed between pre-op and post-op day 4. This trend was not present in the high strain 
group. Strain was also cut off at 0.1 (the cutoff used in Aim 3A of this work). The lower cutoff 
clearly exacerbated the increase in areas. Given that only 2 animals fell below the 0.1 cutoff, 
statistical measures were not employed on areas.  
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Figure 7-9: Differences in cross-sectional area between low and high strain groups. A) Histogram of day 4 
strain values with strain cut off at 0.16 (minimum control value). B) Diastolic areas for low strains (<0.16) and high 
strains (>0.16). C) Systolic areas for low strains (<0.16) and high strains (>0.16). D) Histogram of day 4 strain values 
with strain cut off at 0.10 (value used in aim 3A). E) Diastolic areas for low strains (<0.1) and high strains (>0.1). F) 
Systolic areas for low strains (<0.1) and high strains (>0.1). 
7.3.5 Immunohistochemical analysis 
The medial layer of the vessel appeared normal at day 4, with consistent expression of 
myosin heavy chain throughout. Similarly, consistent expression of CD-31 was visible along the 
luminal surface suggesting that the endothelium was intact at day 4. Interestingly, cells 
expressing CD-45 were also observed at the luminal surface in 40% of experimental arteries 
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examined but not in control arteries. At some points, these cells appear to be disrupting the 
layer of CD-31 positive cells, while other regions demonstrate co-expression of CD-31 and CD-
45. Based on IHC analysis of only 1-2 sections per artery, however, there does not appear to be a 
correlation between CD45 expression and low strain magnitude. Figure 7-10 shows a 
representative image of an experimental artery stained for expression of all three markers.  
 
Figure 7-10: Myosin heavy chain, CD-31 and CD-45 expression. A) Hoechst dye indicating nuclei (blue), B) 
Myosin Heavy Chain indicating contractile smooth muscle cells (green), C) CD-31 a marker expressed by endothelial 
cells, D) CD-45, an antigen common to leukocytes. E) Merge of all images. All scale bars: 25 μm. 
In addition to cell types, expression of Ki-67, a marker of proliferating cells was assessed. Ki-
67 expression was found in the vessel wall or on the luminal surface in 90% of animals assessed 
(n=10). Qualitative assessment of Ki-67 positive cells suggests that cells are recruited to both the 
lumen and adventitial layer of the vessel wall. Ki-67 positive cells were not found at the wall of 
any control sections. 
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Figure 7-11: Ki-67 and αSMA expression in control and experimental arteries. A) Sham control artery, B) 
Contralateral control artery, C) Experimental artery. Immunofluorescence stain show nuclei in blue (Hoechst 33342), 
alpha smooth muscle actin in green, and ki-67 in red. White arrows indicate cells at the vessel wall expressing ki-67. 
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Finally, synthesis of the GAGs hyaluronic acid and versican was assessed. No versican 
synthesis was observed in arteries in any of the experimental groups. HA expression was seen 
in experimental animals but no obvious qualitative differences in expression levels were 
observed between control and experimental arteries (Figure 7-12). 
 
Figure 7-12: Hyaluronic acid and versican expression in control and experimental arteries. A) Baseline (no 
surgery) control artery. B) Sham control artery. C) Contralateral control artery. D) Experimental artery. Stain shows 
nuclei (Hoechst) in blue, versican in green and hyaluronic acid in red.  
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7.4 Discussion 
In the earlier chapters of this dissertation, we demonstrated a promising relationship 
between early reductions in mechanical strain and the eventual formation of intimal 
hyperplasia. The major assumption made in those chapters, however, was that significant 
intimal hyperplasia had not formed by the day 4 timepoint. In this chapter, we both verify our 
assumption from previous chapters and enhance our understanding of early changes in the 
vessel wall at the cellular level.  
In support of our findings in chapter 6, we observed a significant reduction in mechanical 
strain at day 4 compared to pre-op in our experimental group but no changes in the control 
groups. Interestingly, the reductions in strain observed in this study were not as severe as those 
seen in the chapter 6 study (with day 4 strains in this chapter of 0.18 ± 0.01 and the chapter 6 
strains of 0.11 ± 0.02). We suspect that this difference between the two studies is likely due to 
biological variability and variability due to different surgeons performing the surgery. Another 
interesting difference between this study and the previous study is that changes in strain here 
appear to be due to decreases in systolic area rather than increases in diastolic area. Despite the 
minor differences between the day 4 outcomes between this study and the chapter 5 study, it 
remains clear that reductions in strain occur at day 4 in this model.  
In addition to pre-op and day 4 data, we also assessed strains immediately after creating the 
stenosis. Reductions in oscillatory strain were not observed immediately after placement of the 
stenosis. This suggests that reductions in strain are not an immediate mechanical effect of focal 
stenosis creation, but rather a change in mechanical properties caused a biological reaction to 
focal stenosis creation. 
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Diastolic and systolic areas were also assessed using ultrasound. Data in Figure 7-6 
demonstrates that, shortly after stenosis formation, the experimental cross-sectional area at both 
diastole and systole are decreased while the contralateral control areas are increased. By day 4, 
however, the contralateral control arteries return to their baseline levels while the experimental 
systolic area remains reduced. To better compare the data from this aim to the data in Aim 3A, 
area data was stratified using a strain cutoff. In Figure 7-9, strains were cut off using the lowest 
control artery strains at day 4, as well as the 0.1 cutoff used in Aim 3A. These data show a 
similar trend toward increase in diastolic area at day 4 to that found in Aim 3A. Additionally, 
systolic areas are seen to decrease in low strain groups at day 4. These data demonstrate the 
importance of assessing oscillatory wall strain at day 4. Although vessel diameters may vary 
from animal to animal and need to be assessed before IH formation. Strain, on the other hand, 
can provide evidence of changes in wall properties based on data from only one time point. 
Intimal and wall thicknesses were assessed at day 4 to improve our understanding of the 
temporal progression of IH in this model. The data in this chapter support our assumption in 
previous chapters that IH has not formed at the day 4 timepoint in this model. No significant 
differences in wall thickness or intimal thickness were observed at day 4 amongst the three 
groups.  We do, however, observe differences between control arteries and experimental 
arteries at the cellular level. Recruitment of leukocytes to the vascular wall appears to occur at 
or before the day 4 timepoint as well as some interruption in the expression of CD-31 at the 
arterial lumen; both hallmark signs of the beginnings of IH.14, 237 Additionally, staining for Ki-67 
demonstrates some proliferating cells in the vicinity of the vessel wall.  
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The lack of significant IH at day 4 observed in this chapter, combined with the day 4 
reductions in strain observed in chapter 5 and this chapter suggest an important mechanistic 
role for strain reduction in the formation of IH. Since we demonstrate that wall thickness 
increases have not occurred at day 4 and other research suggests that pressure reductions will 
not occur in the region proximal to the stenosis,235 the culmination of our data suggests that 
early changes in wall mechanical properties drive the reductions in strain we observed. By 
observing these changes the methods described herein have potential to help predict the 
formation of IH in this model. 
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8 Conclusions and Future Work 
8.1 Conclusions 
Coronary and peripheral artery diseases remain a major cause of morbidity and mortality in 
the United States.1 Although the underlying causes of these diseases remain largely unknown, 
evidence suggests that a major initiating factor of these diseases is Intimal Hyperplasia (IH).3, 6-9 
A number of researchers have correlated local differences in the mechanical environment with 
neointimal formation and arteriosclerosis.14, 19, 20 Despite the extensive evidence suggesting the 
role of shear stress in IH formation, others have demonstrated that shear based explanations 
alone fail to predict IH.27, 28 In this dissertation, we demonstrate that arteries form IH in response 
to changes in a different mechanical force, oscillatory wall strain. Herein, we hypothesized that 
reductions in oscillatory wall strain precede the formation of IH in our murine model of IH.  
In order to test this hypothesis, we developed a novel method to noninvasively measure 
mechanical strains on the murine arterial wall. Although the murine model is attractive as a 
research tool, mouse studies are complicated by both the small vessel size and high heart rates 
seen in the murine model. To overcome these issues, we first adapted the combination of high 
frequency ultrasound with speckle tracking from the cardiac literature 40-42 for use in the 
measurement of oscillatory wall strains in the mouse artery.44 In the first objective of Aim 1, we 
used an in vitro vascular phantom to show a correlation between ultrasound-based strains and a 
previously validated optics-based strain measurement system.181, 183To test the in vivo 
measurement capabilities of our strain measurement approach, in objective 1B, we applied our 
approach to a mouse model of aortic aneurysms. In this in vivo study, we demonstrated the 
ability of our measurement approach to measure significant changes in aortic strains due to a 
vascular disease in the murine model.  
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The methods and data presented in this dissertation provide compelling evidence 
suggesting a correlation between early reductions in mechanical strain and the eventual 
formation of IH. The animal model discussed herein and developed by Tao et al.37 is unique in 
that it does not directly injure or occlude any blood vessel unlike most other models.230-232 
Interestingly, we still reveal a similar intimal hyperplastic response to those studied 
previously.161, 230, 231 Given that both the original model study,37 and subsequent study238 using 
this model both report that only a subpopulation of mice given a focal stenosis go on to form 
IH, we suspect that biological variation amongst the animals plays a role in clinical outcome at 
day 28. Herein we suggest that changes in the mechanical environment, particularly 
circumferential wall strain, play a key role in determining neointimal formation. 
We found that reductions in strain at 27 days after focal stenosis occur in the regions of the 
carotid artery with the most hyperplasia, while those with higher strains had less neointima 
formation. Even though this phenomenon supports our hypothesis, the significant increase in 
wall thickness seen at day 28 likely played a role in causing strain reductions. From a 
mechanical standpoint, we expect that one of three changes will result in mechanical strain 
reduction. Increases in wall thickness directly increase the load bearing cross-sectional area over 
which wall forces are applied; our data in Aim 2 demonstrate that increased cross-sectional area 
has occurred at day 28. Decreases in luminal pulse pressure could also play a role in decreasing 
vascular strain. Since strains measured in this studied are measured proximal to the focal 
stenosis, we do not expect that there is any change in pressures in these animals. Finally, an 
increase in wall stiffness could cause a decrease in wall strain. At day 27, we expect this to be 
true as well due to the reported increase in collagen content in our model.37 To assess whether 
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the strain reductions were caused by increased wall thickness or by other factors, we assessed 
strains and IH at earlier time points. 
Herein, we probed the temporal changes in both IH and mechanical strain in the focal 
stenosis model. In Objective 3A, we re-examined histological data from Aim 2 and compared 
histological outcome at day 28 to strains at just 4 days after focal stenosis creation. The results of 
this objective demonstrated that the reductions in strain we saw at day 28 had already occurred 
at day 4 post-op. This finding suggests that the changes in strain may precede the formation of 
IH. The results of Objective 3A also revealed that, on a region by region basis, some regions had 
low strain at day 4 while others had higher strains (close to baseline). Further, we discovered 
that there was statistically lower IH formation at day 28 post-op in regions with high day 4 
strains vs. regions with low day 4 strain.  
The final piece of evidence needed to fully support the overall hypothesis of this 
dissertation was to show that IH does not form by day 4 post-op. In objective 3B we examined 
both neointimal formation at post-op day 4 and the changes in strain found immediately post-
op. Our quantification of intimal and wall thickness at day 4 post-op demonstrated no 
significant changes in gross wall morphology at day 4. These data suggest that the reductions in 
strain both precede IH in this model and are not due solely to increases in wall thickness. 
Additionally, post-op day 0 data (Objective 3B) demonstrated that no immediate decrease in 
strain occurs after focal stenosis creation. This evidence suggests that changes in wall 
morphology between post-op day 0 and day 4 results in the strain reductions we find in this 
model. 
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Previous models of IH in the mouse model have identified that cellular proliferation and 
inflammatory cell recruitment to the region are the events that initiate eventual intimal 
hyperplasia.14, 237 In this study, we find that, similar to other studies, leukocytes (CD45+ cells) are 
recruited to the endothelial wall by day 4. This suggests that the beginning of an inflammatory 
response is occurring. One group has demonstrated that a circulating cell type, the fibrocyte, 
which is known to express cd45 is recruited to the vascular wall at the onset of intimal 
hyperplasia.239 Additionally, Varcoe et al. identified that these fibrocytes also expressed cd31 
when recruited to the vascular wall, a phenomenon we observed in Aim 3B.240 Similarly, we 
observed cells in the vascular wall that co-expressed CD31 and CD45. 
To support our cellular findings, we also examined ki-67 expression to probe proliferation at 
the vessel wall. Our findings demonstrate that the majority of experimental arteries at day 4 
contain cells that express Ki-67, a marker of proliferating cells. This finding is significant 
because cellular proliferation is considered a hallmark of intimal hyperplastic responses.14, 86In 
addition to cellular recruitment, we assessed expression of GAGs in the vascular wall at day 4. 
Looking at both versican and hyaluronic acid (HA) expression, we observed no obvious 
differences in the expression of either GAG at day 4. Chajara et al. previously demonstrated that 
rat aortas express HA in the neointima 14 days after balloon injury as well as expression in the 
adventitia at baseline.229 Given that our day 4 histology was completed prior to neointima 
formation, we did not see HA synthesis at the wall. Versican expression was also assessed. At 
day 4, we did not observe versican expression in any experimental or control arteries. This 
suggests that versican expression does not occur in this model or that it occurs downstream of 
strain reduction. 
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The clinical relevance of this model differs from that of previous models in that it does not 
focus on deliberate endothelial injury as the underlying cause of IH. Many previous studies 
focus on the effects of either balloon angioplasty or wire injury (or denudation) of the 
endothelium on subsequent IH.14, 108, 237 Interestingly, we and others have found that IH forms 
without causing any apparent injury to the endothelium. As a result, the relevance of both this 
model37 and the subsequent work in this dissertation is mainly to the underlying mechanisms of 
IH, without endothelial injury. Based on the data at hand, we suspect that reductions in luminal 
flow lead to structural changes in the vessel wall between the focal stenosis creation and day 4 
post-op. These changes result in oscillatory strain reduction and eventually lead to leukocyte 
infiltration, cellular proliferation and intimal hyperplasia.   
 
Figure 8-1: Summary of the results of this dissertation. 
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8.2 Limitations 
The experiments in this dissertation are limited by a number of factors. First and foremost, 
the present study did not directly decouple the effects of other mechanical forces on the wall 
from mechanical strain. Namely, we did not compute wall tensile stress or wall shear stress in 
these studies. In order to assess wall stress, it would have been necessary to measure luminal 
pressures in the carotids during the study. Unfortunately, given the relatively large size of the 
smallest commercially available pressure catheters (0.9 French size/300 μm) compared to the 
inner diameter of the mouse carotid artery (300-400 μm),37, 225 insertion of a pressure catheter 
would likely impede or change blood flow in the artery. Despite this limitation, others have 
assessed systemic pressure changes in similar flow reduction models and have not observed 
significant pressure changes in the proximal region.235 Blood flow through the stenosed blood 
vessel was also not assessed. In the published study describing the focal stenosis model, an 
average of 85% reduction in blood flow was reported immediately after stenosis.37 We have not, 
however, determined if a correlation exists between different levels of blood flow and resultant 
IH in this model. Given that all of the comparisons made in this study are between animals of 
the same age and strain, with focal stenoses made by the same lab team, it is not likely that 
measurable differences in blood flow through the arteries would be observed. 
The results in Objective 1A demonstrated a large difference between strains measured via 
ultrasound at the tubing lumen and strains measured via HDM at the tubing outer wall. 
Theoretical analysis of these relations assuming constant tubing wall volume demonstrated this 
difference in strains was largely due to the thickness of the tubing. Although others have used 
 109 
Chapter 8: Conclusions and Future Work 
thin wall assumptions to simplify modelling of carotid arteries241 our results suggest that some 
arteries must be considered as thick walled vessels depending on the ratio of vessel wall 
thickness to radius. In our silicone tubing vessel analog, the ratio of wall thickness to outer 
radius was 0.25 while sham arteries at day 4 had a ratio of only 0.13±0.02 (by histology). This 
much smaller ratio would likely allow for accurate determination of wall strains using thin wall 
assumptions. In our day 28 arteries, however, the ratio of wall thickness to wall radius averaged 
0.46±0.13. In the case of day 28 arteries, thick wall assumptions should apply. Future studies 
should carefully consider the wall thickness of arteries with IH to determine if thin wall 
assumptions apply. Despite this limitation in approach, we expect the luminal surface of the 
vessel, the region where we measured strain with ultrasound, to have the highest wall stress 
and strain. 242Limitations to our strain measurement methodologies are also recognized. Only 1 
dimensional strain was assessed in this study. Given the lack of contrast between the outer wall 
of the carotid artery and the surrounding tissue, we were only able to measure luminal strains 
in the circumferential direction and longitudinal strains were not assessed. Given that the 
circumferential strain is known to be the most prominent strain on the vessel wall, it is likely 
that the greatest changes in strains will be observed in the circumferential direction. Finally, our 
ultrasound approach is limited by our ability to orient the probe perpendicular to the artery in 3 
dimensions. Variations in probe angle can lead to smaller or larger diameter measurements 
using ultrasound, which may increase animal to animal variability in diameter measurements. 
Since we measure oscillatory strains based on systolic and diastole without changing probe 
angles, we do not suspect this variation significantly affected strain our measurements. 
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8.3 Future work 
In this dissertation, we developed a novel method of measuring murine arterial strains 
noninvasively and demonstrate a promising correlation between oscillatory strain reduction 
and IH formation in this model. We identified that changes in wall tensile stress and wall shear 
stress may also play a role in IH formation in this model. Consequently, it will be important in 
future studies to directly assess these mechanical factors and determine their relation to IH 
outcome in this model. As a result of these limitations, a crucial future step would be to 
measure pressure simultaneously with strain measurements. Since we believe that insertion of a 
pressure catheter into the carotid would result in extreme changes in local hemodynamics, 
simultaneous systemic pressure recordings should be used (in either the aorta or femoral artery) 
to estimate carotid pressure. Additionally, future studies should use either pulsed wave 
Doppler ultrasonography or a flow probe to measure flow through the carotid artery.  
In the results of this dissertation we identified that changes in mechanical strain, 
particularly those driven by increased diastolic area, lead to IH formation. This finding suggests 
that compositional changes in the arterial wall are causing changes in its mechanical properties. 
The major component of the arterial wall that contributes to its ability to distend under pressure 
is elastin.243 The mechanical results presented herein suggest that, assuming luminal pressure 
does not change significantly, the stiffness of the artery may be increasing in the first few days 
after creation of the focal stenosis. Interestingly, in vitro research into abdominal aortic 
aneurysms has demonstrated that elastin degradation assays result in increased vascular 
stiffness and increased vessel diameters.228 This similarity between in vitro elastin degradation 
and our in vivo results suggests a mechanism that may drive strain changes in our model. 
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Future studies should look in greater detail into the structural changes in elastin in our model of 
IH. Others have accomplished this using multi-photon microscopy and have demonstrated that 
fibers can be extracted and angles can be quantified.244 Application of such a tool to our model 
could allow for direct comparison of elastin structural changes to reductions in mechanical 
strain. In collaboration with Yanhang Zhang, Ph.D. at Boston University, we have begun to 
analyze the elastin and collagen structure of blood vessels from our murine model using two-
photon microscopy (Figure 8-2). The results of these preliminary analyses demonstrate that 
elastin structure at the vessel’s medial surface appears to be less organized at day 4 in 
experimental animals compared to baseline arteries. Others have demonstrated that inhibition 
of matrix mettaloproteinases (MMPs) prevents elastin breakdown and minimizes IH in 
arteriovenous grafts.245 This evidence suggests that release of MMPs from leukocytes recruited 
to the vessel wall may result in the elastin breakdown observed by the Zhang lab; which could 
produce the strain reductions presented in this dissertation. Future studies should focus on 
quantifying the elastin organization and orientation using two-photon microscopy images. 
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Figure 8-2: Two-photon microscopy analysis of medial elastin and collagen View of the internal surface of a 
murine artery showing collagen and elastin structure. A) Baseline artery demonstrating wavy, structured elastin 
structure and B) Day 4 experimental artery showing less structured elastin interrupted by collagen. Tissue processing 
and image acquisition courtesy of Ming-Jay Chow, Raphael Turcotte and Yanhang Zhang Ph.D. from Boston 
University 
In addition to assessment of elastin structure, the mechanisms behind IH in this model 
could be better understood by determining the point at which IH cannot be reversed. Given that 
our results suggest that creating a focal stenosis leads to structural changes and mechanical 
strain reductions and leads to IH, it may be important to understand if removal of the suture at 
day 4 would return the artery to its initial strain levels and if removal of the suture would 
prevent formation of IH at day 28. 
Another major finding in this dissertation is the presence of leukocytes and proliferating 
cells at the vessel wall as early as day 4. Since the immunohistochemical analyses presented 
herein are decidedly preliminary, it will be necessary for future studies to analyze the cellular 
activity in greater detail. In particular, regional differences in leukocyte recruitment (differences 
along the length of the vessel) should be assessed. Additionally, leukocytes and proliferating 
cells should be counted in each region of the vessel and correlated with oscillatory wall strain 
levels. This can be accomplished by counting nuclei that either co-express Ki67 or which are 
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surrounded by CD45 staining. Future work should also aim to assess the specific cell types seen 
proliferating at the wall and the specific type of leukocytes seen at the wall (i.e. markers that 
identify macrophages such as CD68). 
Further, this dissertation could provide the groundwork for future therapies for treating IH. 
The data herein suggest that mechanical strain reductions play a role in IH formation. Given the 
elastin degradation observed by the Zhang lab using two-photon imaging, an important first 
therapeutic step would likely be to increase the cyclic stretch on the vessel wall by either 
increasing elastin content in the vascular wall or providing mechanical support to the vessel via 
some other means, such as an external cuff. A number of previous studies have demonstrated 
that external reinforcement of vein grafts can reduce intimal hyperplasia and medial 
thickening.246-249 The data presented herein suggest that by adding external support to arteries 
may reduce IH as well. Additionally, our data suggest that the compliance of the external 
supporting the vessel may be important. By changing the mechanical stretch applied to the 
vessel wall, our data suggest that IH formation could be reduced. 
Finally, the results of this study could provide the foundation for future clinical 
applications. Ultrasound imaging is commonly used in the clinical setting to assess patients 
with vascular diseases. The approach described herein could be used on top of existing clinical 
US scans to provide noninvasive measurements of arterial wall strains. The ability to determine 
the structural properties of arteries based on noninvasive strain measurements could be applied 
as a first level determination of susceptibility to IH and the vascular diseases that result from it. 
Vessels with inherently low strain could have altered mechanical properties that make them 
prone to failure. In the work described herein, we demonstrate that strains below around 10 -
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14% in the murine model may cause susceptibility to IH. If a similar strain threshold level could 
be determined in human arteries, this parameter could provide additional data to physicians 
and aid in determination of the appropriate vascular intervention. If this correlation exists in 
human arteries, it may allow for more efficient prediction of arterial susceptibility to occlusion. 
For example, patients with low oscillatory wall strain will likely need an intervention to 
overcome the rapid progression of IH.  Patients with high oscillatory wall strain may not need 
an immediate intervention. The relationships demonstrated in this dissertation could be used to 
improve the diagnosis of vascular disease.
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Appendix B: Staining protocols and controls 
Masson’s Trichrome  
This protocol was provided courtesy of the WPI Gateway Park histology core. 
Biebrich Scarlet Acid Fuchsin stock solution (Red) 
Biebrich scarlet aqueous 1%   90.0ml 
Acid Fuchsin aqueous 1%   10.0ml 
Glacial Acetic Acid 100%   1.0ml  
Biebrich scarlet aqueous 1%  
 Biebrich Scarlet     1.0gm 
 DH2O      99.0ml 
Acid Fuchsin aqueous 1% 
 Acid fuchsin     1.0gm 
 DH2O      99.0ml 
Phosphomolybdic-Phosphotungstic Acid Solution (Yellow) 
Phosphomolybdic acid   5.0gm 
Phosphotungstic acid   5.0gm 
DH2O      200.0ml 
Aniline Blue solution (Blue) 
Aniline blue     2.5gm 
Glacial Acetic acid 100%   2.0ml 
DH2O      100.0ml 
1% Glacial Acetic Acid solution 
Glacial acetic acid 100%   1.0ml 
DH2O      100.0ml 
Hematoxylin Solution A 
 Hematoxylin crystals    1.0gm 
 95% Alcohol     100.0ml 
Hematoxylin Solution B 
 Ferric Chloride, 29% aqueous 4.0ml 
 DH2O      95.0ml 
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 Hydrochloric acid, concentrated  1.0ml 
Ferric chloride 29% 
 Ferric chloride     29.0gm 
 DH2O      100.0ml 
Weigerts Iron Hematoxylin solution 
Equal parts of solution A and B 
 
Run a control slide.      Control tissue: Heart, uterus, skin. 
Safety equipment: Work under a hood with lab coat, gloves, and glasses. 
1. De-paraffin slides in xylene (1)---------------------- 2 minutes (re-use) 
2. De-paraffin slides in xylene (2)---------------------- 2 minutes (re-use) 
3. Clear slides in 100% alcohol------------------------- 2 minutes 
4. Clear slides in 100% alcohol------------------------- 2 minutes 
5. Hydrate slides in 95% alcohol----------------------- 2 minutes 
6. Hydrate slides in running water--------------------- 5 minutes 
7. Bouin’s at 60 degrees Celsius----------------------- 1 hour (re-use) 
8. Wash in running water ------------------------------ 10 minutes  
9. Weigert’s Hematoxylin (make fresh)  -------------- 10 minutes (dump) 
10. Wash in running water -------------------------- 10 minutes  
11. Biebrich Scarlet Acid Fuchsin----------------------- 10 minutes (re-use) 
12. Rinse in running water------------------------------ 2 minutes  
13. Phosphomolybdic / Phosphotungstic acid------ 10 minutes (re-use) 
14. No rinse, goes directly into blue 
15. Aniline Blue--------------------------------------------------- 10 minutes (re-use) 
16. Rinse in running water-------------------------------- 1-2 minutes  
17. 1% Glacial Acetic Acid--------------------------------- 5 minutes (re-use) 
18. Dehydrate in 95% alcohol----------------------------- 1 minute 
19.   Dehydrate in 95% alcohol--------------------------- 1 minute 
20.   Dehydrate in 100% alcohol------------------------- 1 minute 
21.   Dehydrate in 100% alcohol------------------------- 1 minute 
22.   Dehydrate in 100% alcohol------------------------- 5 minutes 
23.   Clear in xylene (4)------------------------------------- 2 minutes (re-use) 
24.   Clear in xylene (5)------------------------------------- 5 minutes (re-use)  
 
Results: 
Nuclei- Black 
Cytoplasm, keratin, muscle fiber and intercellular fibers- Red 
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Collagen- Blue 
Weigerts Iron Hematoxylin: 
Equal parts of solutions A and B – 20ml and 20ml for tall glass staining coplin jar. 
 
 
  
 150 
Appendices 
Ki-67 and alpha Smooth Muscle Actin 
Control tissue 
 Mouse intestine (+) 
 Use primary delete negative control 
Sample positive control below (left) and negative control (right) with alpha smooth muscle 
actin in green, Ki-67 in red and nuclei in blue 
  
 
Deparaffinize 
Materials 
 Xylene 
 Ethanol 
 DI water 
 Tap water 
Procedure 
1. Xylene 1 for 3 minutes 
2. Xylene 2 for 3 minutes 
3. 100% ethanol for 3 minutes 
4. 100% ethanol for 3 minutes 
5. 95% ethanol for 3 minutes 
6. 70% Ethanol for 3 minutes 
7. 50% ethanol for 3 minutes 
8. Rinse in running tap water for 5 minutes 
Heat induced epitope retrieval 
Materials 
 Tris-EDTA buffer (pH 9.0) 
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o 1.21 grams Tris HCl (MP Biomedical, 816124) 
o 0.37 grams Ethylenediaminetetraacetic acid (EDTA. Sigma, ED4SS) 
o 1000 mL Distilled water 
o 0.5 mL Tween 20  
Mix Tris, EDTA and DI water. pH should be near 9.0 but adjust as necessary. Add Tween 20 
 Pressure cooker 
Procedure 
While deparaffinizing slides, bring 1L Tris-EDTA buffer to a boil in the unsealed pressure 
cooker. Once buffer is at a rolling boil, transfer slides to a metal slide rack and place in the 
boiling buffer solution. Seal the pressure cooker and wait until it reaches full pressure (gas 
escapes pressure release valve). Time 3 minutes from onset of full pressure. After 3 minutes, 
transfer pressure cooker to sink, release pressure and run cold water into pressure cooker for 10 
minutes. 
 
Staining protocol 
Materials 
 Phosphate buffered saline (PBS) 
 0.25% Triton-X 100 in DI H2O  
 5% Goat serum in PBS 
 3% Goat serum in PBS 
 Primary:  
o Mouse anti Alpha, smooth muscle actin monoclonal 1:50 (Abcam,AB7817) 
o Rabbit anti Ki-67 monoclonal 1:100 (Sigma,AB16667) 
o In 3% goat serum  
 Hoechst dye 1:6000 in PBS 
 Secondary:  
o Alexa-fluor 488 goat anti-mouse 1:400 (Invitrogen A11029) 
o Alexa-fluor 568 goat anti-rabbit 1:400 (Invitrogen A11036) 
o In 3% goat serum 
 Cytoseal-60 
Procedure 
1. Wash 3x in PBS for 5 mins 
2. Permeabilize with 0.25% Triton X for 20 mins 
3. Block with 5% goat serum in PBS for 30 mins 
4. Incubate in primary antibody overnight at 4 degC 
5. Wash 3x in PBS for 5 mins 
6. Incubate in secondary antibody for 1 hr at room temperature 
7. Wash 3x in PBS for 5 mins 
8. Counterstain with Hoechst for 5 minutes 
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9. Wash 3x in PBS for 5 mins 
10. Coverslip with cytoseal-60 
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Hyaluronic acid and Versican 
Control tissue 
 Mouse heart valve (+)—Use longitudinal sections of the mouse heart 
 Use primary delete negative control 
Sample positive control below (left) and negative control (right) with versican in green, 
hyaluronic acid in red and nuclei in blue 
  
Deparaffinize 
Materials 
 Xylene 
 Ethanol 
 DI water 
 Tap water 
Procedure 
1. Xylene 1 for 3 minutes 
2. Xylene 2 for 3 minutes 
3. 100% ethanol for 3 minutes 
4. 100% ethanol for 3 minutes 
5. 95% ethanol for 3 minutes 
6. 70% Ethanol for 3 minutes 
7. Rinse in running tap water for 5 minutes 
Staining protocol 
Materials 
 Control tissues: Artery (+) and (-), Heart with valves visible (+) and (-) 
 PBS 
 5% Goat serum in PBS 
 Sodium acetate buffer 
o NaOAc 50 mM (0.41%) 
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o NaCl 0.15 M (0.87%) 
o pH 6.0 in D.I. water 
 Primary hyaluronidase (-) control 
o 20 units/mL Hyaluronidase from Bovine testes (Sigma, H3506) 
o In Sodium Acetate Buffer 
 Primary:  
o Hyaluronic acid binding protein-biotinylated 3 ug/mL, 1:30 (Sigma, H9910) 
o Rabbit anti-mouse Versican 1:150 (Millipore, AB1033) 
o 0.1% BSA, 3% Goat serum in PBS  
 Secondary:  
o Alexa-fluor 488 goat anti-rabbit 1:400 (Invitrogen, A-11008) 
o Alexa-fluor 568 Streptavidin 1:400 (Invitrogen, S-11226) 
o 0.1% BSA, 3% goat serum in PBS 
 Hoechst 33342 dye 1:6000 in PBS () 
 Cytoseal-60  
Procedure 
1. Wash 3x in PBS for 5 mins 
2. Permeabilize with 0.25% Triton X for 20 mins 
3. Wash 3x in PBS for 5 mins 
4. Perform Enzyme digestion of HA in negative controls (Leave positive controls in 
Sodium acetate buffer) for 1 hr at 37 degC 
5. Wash 3x in PBS for 5 mins 
6. Block with 5% goat serum/1% BSA in PBS for 1 Hour 
7. Incubate in primary antibody overnight at 4 degC 
8. Wash 3x in PBS for 5 mins 
9. Incubate in secondary antibody for 1 hour at room temp 
10. Wash 3x in PBS for 5 mins 
11. Counterstain with Hoechst for 5 minutes 
12. Wash 3x in PBS for 5 mins 
13. Coverslip with cytoseal 
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Myosin Heavy Chain, CD-31 and CD-45 
Controls 
Intestine control (CD-45 in yellow shows up clearly) Positive control (right) and primary delete 
control (left) 
   
 
Heart control (Myosin heavy chain in green and CD-31 in red). These two stains are clearly 
visible in the blood vessels in the heart. Note that surrounding myocardium is not stained. 
    
Deparaffinize 
Materials 
 Xylene 
 Ethanol 
 DI water 
 Tap water 
Procedure 
1. Xylene 1 for 3 minutes 
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2. Xylene 2 for 3 minutes 
3. 100% ethanol for 3 minutes 
4. 100% ethanol for 3 minutes 
5. 95% ethanol for 3 minutes 
6. 70% Ethanol for 3 minutes 
7. 50% ethanol for 3 minutes 
8. Rinse in running tap water for 5 minutes 
Antigen retrieval 
Materials 
 Citrate Buffer (1mM Citric Acid, 0.05% Tween 20, pH 6.0) 
o Citric acid (anhydrous)  --------------- 1.92 g 
o       Distilled water -------------------------- 1000 ml 
Mix to dissolve. Adjust pH to 6.0 with 1N NaOH and then add 0.5 ml of Tween 20 and mix 
well. Store this solution at room temperature for 3 months or at 4 C for longer storage. 
 Pressure cooker 
Heat induced epitope retrieval 
Materials 
 Citrate Buffer (1mM Citric Acid, 0.05% Tween 20, pH 6.0) 
o 1.21 grams Tris HCl (MP Biomedical, 816124) 
o 0.37 grams Ethylenediaminetetraacetic acid (EDTA. Sigma, ED4SS) 
o 1000 mL Distilled water 
o 0.5 mL Tween 20 () 
Mix Tris, EDTA and DI water. pH should be near 9.0 but adjust as necessary. Add Tween 20 
 Pressure cooker 
Procedure 
 While deparaffinizing slides, bring 1L Tris-EDTA buffer to a boil in the unsealed 
pressure cooker. Once buffer is at a rolling boil, transfer slides to a metal slide rack and 
place in the boiling buffer solution. Seal the pressure cooker and wait until it reaches 
full pressure (gas escapes pressure release valve). Time 3 minutes from onset of full 
pressure. After 3 minutes, transfer pressure cooker to sink, release pressure and run 
cold water into pressure cooker for 10 minutes. 
Procedure 
1. Place citrate buffer in coplin jar 
2. Add coplin jar with citrate buffer to water bath on hot plate 
3. Heat to 90-100oC, incubate for 20-40 minutes 
4. Remove and allow sections to cool in citrate buffer for 20 minutes at room temperature 
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Staining protocol 
Materials 
 Control tissues: Aorta, heart 
 PBS 
 0.25% Triton-X 100 in DI H2O 
 5% Goat serum in PBS 
 Primary:  
o Mouse monoclonal anti smooth muscle myosin heavy chain 1:400 
(Abcam,AB683) 
o Rabbit anti CD-31 monoclonal 1:50 (Abcam 28364) 
o Rat anti Mouse CD-45 1:50 (BD 550539) 
o 3% goat serum  
 Hoechst dye 1:6000 in PBS 
 Secondary:  
o Alexa-fluor 488 goat anti-rat 1:400 (Invitrogen A11029) 
o Alexa-fluor 568 goat anti-rabbit 1:400 (Invitrogen A11036) 
o Alexa-fluor 633 goat anti-mouse 
o 3% goat serum 
 Cytoseal-60 
Procedure 
1. Wash 3x in PBS for 5 mins 
2. Permeabilize with 0.25% Triton X for 20 mins 
3. Block with 5% goat serum in PBS for 30 mins 
4. Incubate in primary antibody overnight at 4 degC 
5. Wash 3x in PBS for 5 mins 
6. Incubate in secondary antibody for 1 hr at room temperature 
7. Wash 3x in PBS for 5 mins 
8. Counterstain with Hoechst for 5 minures 
9. Wash 3x in PBS for 5 mins 
10. Coverslip with cytoseal 
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Appendix C: Derivation of theoretical strain relationship 
 
 
Definitions
Ei
Green's Strain at inner wall
Eo
Green's Strain at outer wall
i
Stretch ratio at inner wall
o
Stretch ratio at outer wall
ro
Outer radius at zero stress state
ri
Inner radius at zero stress state
Ro
Outer radius at stressed state
Ri
Inner radius at stressed state
L Length of tubing
Known relationships
Definition of Stretch ratio
o
Ro
ro
= i
Ri
ri
=Eq 1 Eq 2
Definition of Green's Strain in 1D
Eo
1
2
o
2
1

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2
i 1 =Eq 3 Eq 4
Conservation of tube wall Volume
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Ei= Simplify and solve for Eo
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Appendix D: Determination of vessel layer thickness 
1.  Original image: 
 
2. Thresholded image: 
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3. Extraction of lumen edge: 
 
4. User selection of IEL, EEL and vessel extent: 
 
 
 
 
5. Convert pixel areas to area in microns2: 
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   (Known value for our scope, camera and objective) 
 
 
6. For each area, calculate ideal radius: 
 
 
7. Compute vessel parameters from ideal radii: 
 Intimal thickness: 
  
 Wall thickness: 
 
 
 
R 0.540
m
pixellength
=
Amicron Apix R
2
=
rideal
Amicron
=
tI riel rlumen=
twall rextent rlumen=
